CURRICULUM VITAE
CURRICULUM VITAE
NAME: David Worth Dunn
CURRENT POSITIONS: Arthur B. Richter Professor of Child Psychiatry
Professor, Child Neurology and Psychiatry,
Departments of Neurology and Psychiatry,
Indiana University, School of Medicine,
705 Riley Hospital Drive, Riley 4300
Indianapolis, Indiana 46202
Director, Division of Child and Adolescent Psychiatry, 2012-
Director, Riley Child and Adolescent Psychiatry Clinics,
Training Director, Child and Adolescent Psychiatry and
Triple Board Program, Indiana University School of Medicine,
Indianapolis, Indiana 46202
TELEPHONE: Office: 317/944-8162
Fax: 317/948-0609
EDUCATION: Tulane University
Arts and Sciences, B.A.
New Orleans, Louisiana, 1966-1969
Tulane University
School of Medicine, M.D.
New Orleans, Louisiana, 1969-1973
POSTGRADUATE TRAINING:
Internship - Rotating Medicine
Charity Hospital, New Orleans, Louisiana, 1973-1974
Resident - Pediatrics, 1974-1975
Resident - Neurology, 1975-1977
Chief Resident - Neurology, 1976-1977
Tulane University, New Orleans, Louisiana
Fellow - Pediatric Neurology
Columbia Presbyterian Hospital, New York, NY 1977-1978
Resident - Psychiatry, 1991-1992
Child Psychiatry, 1993-4
Indiana University, Indianapolis, Indiana
ACADEMIC APPOINTMENTS:
Assistant Professor of Neurology and Pediatrics,
Tulane University School of Medicine
New Orleans, Louisiana, 1978-1983
Associate Professor of Neurology (Child) and Pediatrics
Indiana University School of Medicine
Indianapolis, Indiana, 1983-1990
Associate Professor of Psychiatry and Neurology
Indiana University School of Medicine
Indianapolis, Indiana, 1994-2005
LICENSURE: Indiana
CERTIFICATION: American Board of Psychiatry and Neurology
Neurology with Special Competence in Child Neurology, 1980 (lifetime certification)
Psychiatry, 1994: Recertification, 2004; Recertification, 2014.
Child Psychiatry, 1995: Recertification, 2005; Recertification, 2014.
Epilepsy, 2012:
HOSPITAL APPOINTMENTS:
Charity Hospital
New Orleans, Louisiana, 1978-1983
Tulane Medical Center
New Orleans, Louisiana, 1978-1983
Children's Hospital
New Orleans, Louisiana, 1978-1983
Indiana University Hospitals
Indianapolis, Indiana, 1983-
Wishard Memorial Hospital
Indianapolis, Indiana, 1983-
Larue Carter Hospital
Indianapolis, Indiana, 1991-
COMMITTEES:
MEDICAL CENTER:
Director, Neurology Training Program, Tulane University, 1978-1981
Medical Procedures, Children's Hospital, New Orleans, Louisiana, 1980-1981
Spinal Unit Committee, Children's Hospital, New Orleans, Louisiana, 1981-1983
Long Range Planning, Psychiatry and Neurology, Tulane University, 1982-1983
Resource Management Committee, Wishard Memorial Hospital, 1984-1985
Ad Hoc Committee, Riley ICU, Indiana University, 1985-1990
Physical Therapy, Occupational Therapy Medical Advisory, Indiana University, 1985-1990
Pediatric Rehabilitation Task Force, Indiana University, 1987-1988
Director, Child and Adolescent Psychiatry Residency Training, Indiana University, 1998-
Director, Combined Pediatrics-Psychiatry-Child and Adolescent Psychiatry Residency, 1998-
Department of Psychiatry, Indiana University: Resident training, education, and junior year
clerkship committees, 1998-
Director, Riley Hospital Child and Adolescent Psychiatry Outpatient Clinics, 2000-
Interim Director, Division of Child and Adolescent Psychiatry, IUSM, 2011-
COMMUNITY:
Louisiana Committee on Epilepsy and Cerebral Palsy, 1978-1979
Medical Advisory Board, Indiana NF Foundation, 1986-1990
West Africa Trauma Team, Reconciliation and Renewal, Operation Classroom, 1994-2010
Interchurch Federation: Community Violence Reconciliation Task Force 1998-2008
Operation Classroom Taskforce, Indiana United Methodist Church 2007-2010
NATIONAL/INTERNATIONAL:
American Academy of Child and Adolescent Psychiatry
Physically Ill Child Committee 2010-
Alliance on Learning and Innovation Focus Group (AALI) 2012-
Triple Board and Pediatric Portal Committee 2015-
American Academy of Pediatrics
Mental Health Task Force 2004-6
American Board of Psychiatry and Neurology
Examiner, Child Neurology, 1984-2012
Part I Neurology Question-Makers Minor Subcommittee, 1996-2004
Committee on Certification in Epilepsy, 2011-
American Epilepsy Society
International Affairs Committee, 2008-2010
Research Council, 2004-2008
Task force on psychiatric aspects of epilepsy, 2009-2014
Task force on psychogenic nonepileptic seizures, 2009-2015
Pediatric Content Committee 2010-2014
Psychosocial Comorbidity Committee 2014-2016
Child Neurology Society
Constitution and By-Laws, 1984-1985
Nominating Committee, 1988
Membership Committee, 1989-1991
ADHD Practice Parameter Subcommittee, 1995-1996
Epilepsy and Behavior
Editorial Board, 2006-
Epilepsy Foundation
Professional Advisory Board 2004-2012
Nominations committee, quality of life committee, research committee
Epilepsy and Mood Disorders Advisory Group 2003-2007
Epilepsy and Cognition Workgroup 2004-2008
Targeted Research Initiative for Youth, committee chairman, 2006-2012
Grant review committee, 2006-2014
International Editorial Advisory Board of Indian Journal of Pediatrics 2014-2016
International League against Epilepsy 2010-
Commission on Neuropsychobiology 2010-
Neuropsychiatry Commission 2013-
Child Neuropsychiatry Task Force 2010-
Chairman, 2013-
Journal of Child Neurology, 1988-1993
Editorial Board, 1988-1993
National Association of Pediatrics, Psychiatry, and Child and Adolescent Psychiatry Programs
Member, 2003-
Treasurer, 2009-2016
National NF Foundation
Clinical Care Advisory Board, 1987-1990
Chairman, NF Clinics Committee, 1987-1990
National Tuberous Sclerosis Association
Clinical Care Advisory Board, 1990-1994
Clinic Development Committee, 1990-1995
Chairman, 1993-1995
Behavior and Language Subcommittee, 1993-1995
Scientific Advisory Board, 1995-
Center without Walls Taskforce, 2000-2004
Data Base Committee, 2007-2012
Psychiatry, Development, and Neurocognition committee: 2011-
Tuberous Sclerosis Complex Research Program, Department of Defense
Committee member, 2008-2016
Chair, 2012-2014
PROFESSIONAL ORGANIZATIONS:
American Academy of Neurology, 1976-present
Child Neurology Society, 1978-present
Southern Child Neurology Society, 1978-1990
President, 1983-1984
Indiana Neurological Society, 1983-1998
Marion County Medical Association, 1985-1988
International Child Neurology Society, 1989-present
American Epilepsy Society, 1989-present
National Tuberous Sclerosis Alliance, 1990-present
American Psychiatric Association 1991 -present
American Academy of Child and Adolescent Psychiatry 1991 -present
American Association of Directors of Psychiatric Residency Training 1998-present
International League against Epilepsy, 2010-present
GRANTS:
Co-investigator: Childhood epilepsy: factors affecting adaptation. National Institute of
Neurological Disorders and Stroke, PHS 2R01 NR6356, 1990-1995 ($775,917)
Co-investigator: Factors Leading to Behavioral Problems in Children with Seizures.
National Institute of Disabilities and Rehabilitation Research, H133 C20081, 1992-1994.
($49,961)
Co-investigator: Childhood Epilepsy: Factors Affecting Adaptation.
National Institute of Neurological Disorders and Stroke.
HHS PHS2 R01 NS 22416, 1995-2000 ($1,459,909)
Co-investigator: Pilot test of “Be Seizure Smart”: a family seizure management program.
Neuroscience Nursing Foundation, 1997-2000 ($5,000)
Co-investigator: Epilepsy Outcomes in Youth: Neurological and Family Factors.
National Institute of Nursing Research, 1997-2002, PHSR01 NR4536 ($1,568,263)
Co-investigator: Childhood Epilepsy: Factors Affecting Adaptation
National Institute of Neurological Disorders and Stroke
2000-2007, R01NS22416 ($2,949,372)
Co-investigator: Randomized, Double-Blind, Placebo-Controlled, Variable Discontinuation Study in Children with Attention-Deficit/Hyperactivity Disorder. Eli Lilly and Co., $208, 440. 6/11/98-2/15/00.
Co-investigator: Long-Term, Open-Label, Safety Study of Tomoxetine Hydrochloride in Patients 6 Years and Older. Eli Lilly and Co., $220,300. 6/11/98-6/30/00.
Co-investigator: Randomized, Double-Blind Study of Tomoxetine Hydrochloride, Methylphenidate Hydrochloride, and Placebo in Pediatric Outpatients with Attention-Deficit/Hyperactivity Disorder. Eli Lilly and Co., $240,000. 1/1/99-12/30/99.
Co-investigator: A Phase III Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Comparison of Fixed-Dose Ranges (mg/kg/day) of Tomoxetine with Placebo in Child and Adolescent Outpatients with ADHD, Aged 8 to 18 years. Eli Lilly and Co., $300, 726. 4/15/00-4/15/01
Principal Investigator: Efficacy, Tolerability, and Safety of Once-daily Tomoxetine Hydrochloride versus Placebo in Children with Attention-Deficit/Hyperactivity Disorder. Eli Lilly and Co., $171,710. 12/15/00-6/30/01.
Principal Investigator: Long Term, Open-Label, Safety Study of Tomoxetine in Patients, 6 Years and Older. Eli Lilly and Co., $535,193. 6/1/00- 3/09.
Principal Investigator: A Randomized, Double-Blind Study of Tomoxetine Hydrochloride and Placebo in Pediatric Outpatients with Attention-Deficit/Hyperactivity Disorder and Comorbid Tic Disorders. Eli Lilly and Co., $185, 873. 6/15/01 – 06/15/03.
Principal Investigator: A Phase 4, Double-Blind, Placebo-Controlled Trial of Atomoxetine Hydrochloride to Evaluate Efficacy in the School Setting in Children Ages 8 to 12 Years with Attention-Deficit/Hyperactivity Disorder. Eli Lilly and Co., $263, 358. 12/05/01 – 06/03.
Principal Investigator: A Randomized Double-Blind Comparison of Atomoxetine Hydrochloride, Extended-Release Methylphenidate Hydrochloride (Concerta), and Placebo in Pediatric Outpatients with DSM-IV Attention-Deficit/Hyperactivity Disorder. Eli Lilly and Co., $499, 066. 4/02 – 12/03.
Co-investigator: Disruptive behavior disorder with aggressive features and the role of violent media exposure: fMRI study of frontal lobe function. Center for Successful Parenting, $379,493. 7/1/00-6/30/02.
Principal Investigator: A Phase III, Open-Label Study of SPD503 in Children and Adolescents (aged 6-17) with Attention-Deficit/Hyperactivity Disorder. Shire Pharmaceutical Development, Inc. $67,750. 1/01/03 – 6/30/03.
Principal Investigator: A Phase III Open-Label Study of SPD503 in Children and Adolescents (aged 6-17) with Attention-Deficit/Hyperactivity Disorder. Shire Pharmaceutical Development Inc. $89,681. 3/30/03 – 1/31/04.
Co-investigator: Disruptive Behavior Disorder (with Aggressive Features) and the Role of Violent Media Exposure: A Study of Executive Functioning and fMRI Activation in Response to Aggressive-Emotional Tasks.” Center for Successful Parenting, $325,000. 8/1/02-12/31/03.
Principal Investigator: An open-label pilot study of quetiapine addition to Oros methylphenidate in the treatment of ADHD and high-aggression disruptive behavior disorders. Asta Zeneca. $122,858. 08/03- 11/05
Co-investigator: Media Violence Exposure and Brain Functioning in Adolescents: An Experimental Study (Phase III). Center for Successful Parenting. $627,371. 9/04 – 9/06.
Principal Investigator: An Open Label Pilot Study of Quetiapine Addition to Oros Methylphenidate in the Treatment of ADHD and High-Aggression Disruptive Behavior Disorders. AstaZeneca. $122, 858. 08/03 – 11/05.
Co-investigator: A Double-Blind Placebo Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults with ADHD and Comorbid Social Anxiety Disorder. Eli Lilly and Co. $162, 755. 7/05 – 1/07.
Principal Investigator: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Two Fixed Oral Doses of Aripiprazole (10 mg or 30 mg) in the Treatment of Child and Adolescent Patients, Ages 10 -17, with Bipolar I Disorder, Manic or Mixed Episode with or without Psychotic Features. Otsuka. $524,000. 8/05 – 5/07.
Principal Investigator: A Multi-Center, Open-Label Safety and Tolerability Study of Flexible-Dose Oral Aripiprazole (2 mg-30 mg) in the Treatment of Adolescent Patients with Schizophrenia, and Child and Adolescent Patients with Bipolar I Disorder, Manic or Mixed Episode. Otsuka. $119, 563. 08/05 – 5/07.
Principal Investigator: An Open-Label, Dose-Titration, Long-Term Safety Study to Evaluate CONCERTA® at Doses of 36 mg, 54 mg, 72 mg, 90 mg and 108 mg per day in Adults with Attention Deficit Hyperactivity Disorder. Johnson & Johnson. $84,950. 08/06-08/07.
Principal Investigator: A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride given Once a Day in Adults with Attention-Deficit/Hyperactivity Disorder: with a Secondary Examination of Impact of Treatment on Family Functioning. Eli Lilly and Co. $170,900. 07/06-3/2010
Principal Investigator: The Effects of Eltoprazine on Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in Adults: A Double-Blind, Multiple-dose, Crossover, Safety and Preliminary Efficacy Trial. PsychoGenics. $148,906. 07/06-11/07.
Principal Investigator: An open-label, behavioral-treatment-controlled evaluation of the effect of extended release methylphenidate (Ritalin® LA) on the frequency of cytogenetic abnormalities in children 6-12 years of age with attention deficit hyperactivity disorder (ADHD) followed by an observation phase up to 24-months. Novartis. $136,360. 09/06-3/09.
Principal Investigator: A Prospective, Open-Label, Multi-Center, Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse 20-70mg in Children aged 6-12 Diagnosed with ADHD. Shire. $71,788. 9/07- 04/08.
Principal Investigator: A Double-Blind, Placebo Controlled Study of Atomoxetine Hydrochloride for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents with ADHD and Comorbid Dyslexia. Eli Lilly and Co. $204,501. 3/08-12/2010.
Principal Investigator: The Evaluation of LAMICTAL™ as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age. GlaxoSmithKline $ 343,287.
08/08-
Principal Investigator: A Fixed Dose, Randomized, Double Blind, Placebo Controlled Study of LY2216684 in Pediatric Patients with Attention Deficit/Hyperactivity Disorder. (LNBF) Eli Lilly & Co. 8/09-10/2010
Principal Investigator: A Long Term, Open Label Safety Study of LY2216684 in Pediatric Patients with Attention Deficit/Hyperactivity Disorder. (LNDH) Eli Lilly & Co. 8/09-10/15
Principal Investigator: Effect of Duloxetine 30/60 mg Once Daily versus Placebo in Adolescents with Juvenile Primary Fibromyalgia Syndrome. (HMGW) Eli Lilly & Co. 2/11-2014
Principal Investigator: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Molindone Hydrochloride Extended-Release Tablets as Adjunctive Therapy in Children with Impulsive Aggression Co morbid with Attention-Deficit/Hyperactivity Disorder (ADHD). (SPN202). Supernus Pharmaceuticals. 10/11-8/12.
Principal Investigator: Open Label, Extension Study to Evaluate the Efficacy and Safety of Molindone Hydrochloride Extended-Release Tablets as Adjunctive Therapy in Children with Impulsive Aggression Co morbid with Attention-Deficit/Hyperactivity Disorder (ADHD). (SPN203). Supernus Pharmaceuticals. 1/12- 9/12.
HONORS:
Owl Club Award - Tulane University, Clinical Teaching, 1981
Owl Club Award - Tulane University, Clinical Teaching, 1982
Public Service Award, National Neurofibromatosis Foundation, 1990.
Sandoz Award for Academic Achievement,
Indiana University Department of Psychiatry, 1993.
AAP / Mead Johnson Fellow, Association of Academic Psychiatry, 1994.
Resident’s Award for Teaching Excellence, Indiana University Department of Psychiatry, 2001
Indiana University Trustee Teaching Award, 2004
Eugene E. Levitt Section of Psychology Service Award, 2010
American Psychiatric Association, Irma Bland Award for Excellence in Teaching, 2010
Residents’ Award for Teaching Excellence, Indiana University Department of Psychiatry, 2015
PUBLICATIONS:
1. Dunn DW, Snyder CH. Benign paroxysmal vertigo of childhood. Amer J Dis Child 1976; 130:1099-1100.
2. Garcia CA, Dunn DW, Trevor R. Lissencephaly (agyria) syndrome in siblings. Arch Neurol 1978; 35:608-611.
3. King TD, Dunn DW, Faygenbaum D. Chondrodysplasia punctata: Conradi Hunermann form. Amer J Dis Child 1979; 135:1191-1193.
4. Dunn DW. Paroxysmal Dystonia. Amer J Dis Child 1981; 135:381-382.
5. Purvin VA, Dunn DW. Nitroglycerin induced transient ischemic attack. South Med J 1981; 74:1130-1131.
6. Dunn DW, contributor for child neurology sections. In: Waring WW, Jeansonne LO. Practical Manual of Pediatrics. St. Louis, Mosby, 1982.
7. Dunn DW. Acute subdural hematoma following subdural puncture. Amer J Dis Child 1982; 136:371-372.
8. Dunn DW, Reynolds J. Neonatal withdrawal symptoms associated with "T's and blues." Amer J Dis Child 1982; 136:644-645.
9. Dunn DW, Daum RA, Weisberg L, Vargas R. Ischemic cerebrovascular complications of H. influenza meningitis. Arch Neurol 1982; 39:650-652.
10. Gutman I, Dunn DW, Behrens M, Gold AP, Odel J, Olarte MR. Hypopigmented iris spot: an early sign of tuberous sclerosis. Ophthalmology 1982; 89:1155-1159.
11. Dunn DW. Glossopharyngeal neuropathy. South Med J 1983; 76:542.
12. Weisberg LA, Dunn DW. Thalamic gliomas: clinical and computed tomographic correlations. Computerized Radiol 1983; 7:229-235.
13. Dunn DW, Weisberg L, Nadell J. Peduncular hallucinations caused by brainstem compression.
Neurology 1983; 33:1360-1361.
14. Dunn DW, McAllister J, Craft C. Brain abscess and empyema caused by Salmonella. Ped Infect Dis 1984; 3:54-57.
15. Dunn DW, Weisberg L. Serial changes in a patient with congenital CNS toxoplasmosis as observed with CT. Computerized Radiol 1984; 8:133-139.
16. Dunn DW. Factors contributing to delay in diagnosis of bacterial meningitis. South Med J 1984; 77:1115-1117.
17. Temple JK, Dunn DW, Blitzer MG, Shapira E. The muscular variant of Pompe disease: clinical, biochemical and histologic characteristics. Amer J Med Genet 1985; 21:597-604.
18. Dunn DW. Vertebrobasilar occlusive disease and childhood migraine. Pediatr Neurol 1985; 1:252-254.
19. Dunn DW, Lee BI. The child with a single seizure. Indiana Med 1985; 78:873-878.
20. Andreoli SP, Dunn DW, DeMyer W, Sherrod DJ, Bergstein JM. Intraperitoneal deferoxamine therapy for aluminum intoxication in a child on CAPD. J Pediatr 1985; 107:760-763.
21. Dunn DW, Engle WA. Brachial plexus palsy: intrauterine onset. Pediatr Neurol 1985; 1:367-369.
22. Beckerman R, Meltzer J, Sola A, Dunn D, Wegmann M. Brainstem auditory response in Ondine's syndrome. Arch Neurol 1986; 43:698-70l.
23. Dunn DW. Update on seizures and anticonvulsants. Contemporary Pediatrics 1986; 3:50-68.
24. Dunn DW, Epstein LG. Decision Making in Child Neurology. Philadelphia, BC Decker/Mosby, 1987.
25. Dunn DW. CT in ceroid lipofuscinosis. Neurology 1987; 37:1025-1026.
26. Purvin VA, Dunn DW, Edwards M. MRI and cerebral venous thrombosis. Computerized Radiology 1987; 11:75-19.
27. Dunn DW, Weisberg LA. Computed topography of the brain in metabolic diseases involving the central nervous system in children. Computerized Radiology 1987; 11:135-140.
28. Dunn DW, Weisberg LA. Computed tomography of the brain in asphyxiated infants. Computerized Radiology 1987; 11:147-150.
29. Dunn DW. Neurofibromatosis in childhood. Current Problems in Pediatrics 1987; 17(8): 445-497.
30. Dunn DW. Dizziness and vertigo in childhood. Contemporary Pediatrics 1987; 4:67-88.
31. Dunn DW, Roos KL. Neurofibromatosis: an update. Indiana Medicine 1988; 81:207-215.
32. Purvin VA, Hrismalos N, Dunn DW. Varicella optic neuritis. Neurology 1988; 38:501-3.
33. Bognanno JR, Edwards MK, Lee TA, Dunn DW, Roos KL, Lee TA, Klatte EC. Cranial MRI in neurofibromatosis. AJNR 1988; 9:461-8, and AJR 1988; 151:381-8.
34. Dunn DW, Purvin VA. Ophthalmologic manifestations of neurofibromatosis. Smith JL, Katz RS. Neuro-ophthalmology enters the Nineties. Hialeah FL, Dutton Press, 1988; 153-172.
35. Dunn DW. Status epilepticus in children. J Child Neurol 1988; 3:167-173.
36. Dunn DW, Roos KL. Magnetic resonance imaging evaluation of learning difficulties and incoordination in neurofibromatosis. Neurofibromatosis 1989; 2:1-5.
37. Roos KL, Pascuzzi RM, Dunn DW. Neurofibromatosis, Charcot-Marie-Tooth disease, or both?
Neurofibromatosis 1989; 2:238-243.
38. Dunn DW. Status epilepticus in infancy and childhood. Neurologic Clinics 1990; 8:647-657.
39. Dunn DW. Head Trauma. In: Green M, Haggerty RJ. Ambulatory Pediatrics IV. Philadelphia, WB Saunders, 1990; 238-242.
40. Dunn DW, Purvin V. Optic pathways glooms in neurofibromatosis. Develop Med Child Neurol 1990; 32:820-824.
41. Dunn DW. William Henry Day 1830-1907. In: Ashwal S (Ed). The Founders of Child Neurology. San Francisco, Norman Publishing 1990, pp 202-208.
42. Dunn DW, Purvin VA. Headaches in adolescents - practical management strategies for the pediatrician. Adolescent Health Update 1990; 3(1): 1-7.
43. Pavone L, Curatolo P, Rizzo R, Micali G, Incorpora G, Garg BP, Dunn DW, Dobyns WB. Epidermal nevus syndrome: A neurologic variant with hemimegalencephaly, gyral malformation, mental retardation, seizures, and facial hemihypertrophy. Neurology 1991; 41: 266-271.
44. Dunn DW, Parekh HV. Theophylline and status epilepticus in children. Neuropediatrics 1991; 22: 24-26.
45. Dunn DW, Patel H. Ataxia: from the benign to the ominous. Contemporary Pediatrics 1991; 8: 82-96.
46. Roos, KL, Dunn DW. Neurofibromatosis. CA - a Cancer Journal for Clinicians 1992; 42: 241-254.
47. Austin JK, Dunn DW. Children with newly diagnosed epilepsy: impact on quality of life. In Chadwick DW, Baker GA, Jacoby A. Quality of Life and Quality of Care in Epilepsy: Update 1993. Round Table series 31. New York, Royal Society of Medicine Services, 1993:14-26.
48. Purvin VA, Dunn DW. Ophthalmological manifestations of neurofibromatosis 1 and 2. In Huson SM, Hughes RAC. The Neurofibromatoses. London, Chapman and Hall Medical, 1994, pp. 253-274.
49. Austin JK, Oruche UM, Dunn DW, Levstek DA. New-Onset Childhood Seizures: Parents’ concerns and needs. Clin Nurs Prac in Epilepsy 1995; 2: 8-10.
50. Adinamis A, Petti TA, Small J, Nurnberger J, Jr., Dunn D, Patrick V, Kronenberger W. The cyclic dilemma: organic, functional, and environmental interaction in a young teenager. J Am Acad Child Adolesc Psychiatry. 1995; 34:1544-1550.
51. Dunn DW. Cognitive and behavioral manifestations of neurodegenerative diseases. In, Batchelor ES, Dean RS. Pediatric Neuropsychology: interfacing assessment and treatment for rehabilitation. Boston, Allyn and Bacon, 1996, pp85-116.
52. Austin JK, Dunn DW. Assessing children’s concerns about epilepsy. Clin Nurs Prac in Epilepsy. 1996; 3:11-12.
53. Austin JK, Huster GA, Dunn DW, Risinger MW. Adolescents with active or inactive epilepsy or asthma: a comparison of quality of life. Epilepsia 1996; 37:1228-1238.
54. Austin JK, Dunn DW, Price MJ. Health and safety considerations. In, Austin DR. Therapeutic Recreation: processes and techniques. 3rd ed. Champaign, IL, Sycamore Publishing, 1997, pp 389-424.
55. Dunn DW, Patel H. Approach to common office problems of pediatric neurology. In Biller J. Practical Neurology. Philadelphia, Lippincott-Raven Publishers, 1997, pp. 351-366.
56. Patel H, Dunn DW. Epilepsies in children. In Biller J. Practical Neurology. Philadelphia, Lippincott-Raven Publishers, 1997, pp. 402-417.
57. Dunn DW, Austin JK, Huster GA. Behavior problems in children with new-onset epilepsy. Seizure 1997; 6:283-287.
58. Walsh KH, Dunn DW. Complications of psychostimulants. In, Biller J. Iatrogenic Neurology. Boston, Butterworth-Heineman, 1998, pp. 415-431.
59. Austin JK, Huberty TJ, Huster GA, Dunn DW. Academic achievement in children with epilepsy or asthma. Devel Med Child Neurol 1998; 40:248-255.
60. Sokol DK, Dahlmann A, Dunn DW. Hyaluronidase treatment for intravenous phenytoin extravasation. J Child Neurol 1998; 13: 246-247.
61. Austin J, Dunn D, Huster G, Rose D. Development of scales to measure psychosocial care needs of children with seizures and their parents. J Neurosci Nurs 1998; 30:155-160.
62. McNelis A, Musick B, Austin J, Dunn D, Creasy K. Psychosocial care needs of children with new-onset seizures. J Neurosci Nurs 1998; 30:161-168.
63. Shore C, Austin J, Musick B, Dunn D, McBride A, Creasy K. Psychosocial care needs of parents of children with new-onset seizures. J Neurosci Nurs 1998; 30:169-174.
64. Austin JK, Huberty TJ, Huster GA, Dunn DW. Does academic achievement in children with epilepsy change over time? Dev Med Child Neurol 1999; 41:473-479.
65. Austin JK, Dunn DW, Price MJ. Health and safety considerations. In Austin DR. Therapeutic Recreation: Processes and Techniques. 4th Ed. Champaign, IL, Sycamore Publishing, 1999, pp. 425-459.
66. Dunn DW, Austin JK, Huster GA. Symptoms of depression in adolescents with epilepsy. J Am Acad Child Adolesc Psychiatry 1999; 38: 1132-1138
67. Dunn DW, Austin JK. Behavioral issues in pediatric epilepsy. Neurology 1999; 53(Suppl 2): S96-S100
68. Austin JK, Dunn DW, Huster GA. Childhood epilepsy and asthma: changes in behavior problems related to gender and change in condition severity. Epilepsia 2000; 41:615-623.
69. Austin JK, Dunn DW. Children with epilepsy: quality of life and psychosocial needs. Annual Review of Nursing Research 2000; 18:26-47.
70. Huberty TJ, Austin JK, Huster GA, Dunn DW. Relationship of change in condition severity and school self-concept to teacher rations of achievement-related behavior in children with asthma or epilepsy. J School Psychology. 2000; 38:259-276.
71. Huberty TJ, Austin JK, Harezlak J, Dunn DW, Ambrosius WT. Informant agreement in behavior ratings for children with epilepsy. Epilepsy and Behavior 2000; 1:427-435.
72. Dunn DW, Austin JK. Quality of life issues for children and adolescents with epilepsy. In Baker GA, Jacoby A, eds. Quality of life in epilepsy: beyond seizure counts in assessment and treatment. Reading, United Kingdom, Harwood Academic Publishers, 2000, pp. 121-134.
73. Austin JK, Harezlak J, Dunn DW, Huster GA, Rose DF, Ambrosius WT. Behavior problems in children before first recognized seizures. Pediatrics 2001; 107: 115-122.
74. Dunn DW. ADHD, oppositional disorder, and conduct disorder in epilepsy. In: Ettinger AB, Kanner AM, editors. Psychiatric Issues in Epilepsy. Baltimore, Lippincott/Williams & Wilkins, 2001:111-126.
75. Dunn DW, McDougle CJ. Childhood-onset schizophrenia. In: Breier A, Tran PV, Herrera JM, Tollefson GD, Bymaster FP, editors. Current Issues in the Psychopharmacology of Schizophrenia. Philadelphia, Lippincott Williams & Wilkins, 2001:375-388.
76. Dunn DW. Childhood-onset schizophrenia and other psychoses. Emedicine (an on-line textbook), Vol. 2, Sept 14, 2001.
77. Kronenberger WG, Dunn DW. Conversion reaction. In: Maria BL. Current Management in Child Neurology, 2nd Edition. Hamilton, Ontario, BC Decker Inc., 2002:395-399.
78. Austin JK, McNelis AM, Shore CP, Dunn DW, Musick B. A feasibility study of a family seizure management program: ‘Be Seizure Smart.’ J Neurosci Nurs 2002; 34:30-37.
79. Dunn DW, Patel H. Approach to common office problems of pediatric neurology. In: Biller J. editor. Practical Neurology. 2nd Edition. Philadelphia, Lippincott Williams & Wilkins, 2002:407-425.
80. Patel H, Dunn DW. Epilepsies in children. In: Biller J. editor. Practical Neurology. 2nd Edition. Philadelphia, Lippincott Williams & Wilkins, 2002:469-488.
81. Dunn DW, McDougle CJ. Childhood-onset schizophrenia. Child Adolesc Psychopharmacol News 2002; 7(number 2): 1-4.
82. Austin JK, Dunn DW. Progressive behavioral changes in children with epilepsy. In: Sutula T, Pitkänen A. Do Seizures Damage the Brain? Progress in Brain Research 2002; 135:419-427.
83. Sokol DK, Dunn DW, Edwards-Brown M, Feinberg J. Hydrogen proton magnetic resonance spectroscopy in autism: preliminary evidence of elevated choline/creatine ratio. J Child Neurol 2002; 17:245-249.
84. Shore CP, Austin JK, Huster GA, Dunn DW. Identifying risk factors for maternal depression in families of adolescents with epilepsy. J Spec Pediatr Nurs 2002; 7:71-80.
85. Dunn DW, Harezlak J, Ambrosius WT, Austin JK, Hale B. Teacher assessment of behavior in children with new-onset seizures. Seizure 2002; 11:169-175.
86. Dunn DW, Austin JK. Behavioral issues in pediatric epilepsy. Psychiatric Times 2002; 19:25-26.
87. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 2002; 159: 1896-1901.
88. Sokol DK, Dunn DW, Treadwell P. Evaluation and treatment of the patient with neurocutaneous syndromes. In: Batjer HH, Loftus CM, Eds. Textbook of Neurological Surgery. Philadelphia, Lippincott Williams & Wilkins, 2002: Vol. 1, Ch. 23, pp346-358.
89. Austin JK, Dunn DW, Caffrey HM, Perkins SM, Harezlak J, Rose DF. Recurrent seizures and behavior problems in children with first recognized seizures: a prospective study. Epilepsia 2002; 43: 1564-1573.
90. Caplan D, Austin JK, Dunn DW, Shen J, Perkins S. Development of a self-efficacy scale for children and adolescents with epilepsy. Children’s Health Care 2002; 31: 295-309.
91. Dunn DW, Austin JK, Harezlak J, Ambrosius WT. ADHD and childhood epilepsy. Developmental Medicine and Child Neurology 2003; 45: 50-54.
92. Dunn DW, Austin JK, Caffrey H, Perkins S. A prospective study of teacher’s ratings of behavior in children with new-onset seizures. Epilepsy and Behavior 2003; 4: 26-35.
93. Dunn DW. Neuropsychiatric aspects of childhood epilepsy. Epilepsy and Behavior 2003; 4: 101-106.
94. Buelow JM, Austin JK, Perkins SM, Shen J, Dunn DW, Fastenau PS. Behavior and mental health problems in children with epilepsy and low IQ. Developmental Medicine and Child Neurology 2003; 45:683-692.
95. Dunn DW, Kronenberger WG. Attention-deficit/hyperactivity disorder in children and adolescents. Neurol Cl 2003;21:933-940.
96. Kronenberger WG, Dunn DW. Learning disorders. Neurol Cl 2003; 21:941-952.
97. Lagges AM, Dunn DW. Depression in children and adolescents. Neurol Cl 2003; 21:953-960.
98. Fastenau PS, Dunn DW, Austin JK. Pediatric epilepsy. In: Rizzo M, Eslinger PJ, eds. Principles and Practice of Behavioral Neurology and Neuropsychology. Philadelphia, W.B. Saunders Company, 2004: Chapter 45, pp965-982.
99. Dunn DW, Austin JK. Social aspects. In: Wallace SJ, Farrell K, Eds. Epilepsy in Children. 2nd Ed. London, Arnold, 2004: 463-473.
100. Dunn DW, Buelow JM, Austin JK, Shinnar S, Perkins SM. Development of syndrome severity scores for pediatric epilepsy. Epilepsia 2004; 45:661-666.
101. Austin JK, MacLeod J, Dunn DW, Shen J, Perkins SM. Measuring stigma in children with epilepsy and their parents: instrument development and testing. Epilepsy Behav 2004; 5:472-482.
102. Shore CP, Austin JK, Dunn DW. Maternal adaptation to a child’s epilepsy. Epilepsy Behav 2004; 5:557-568.
103. Dunn DW, Austin JK. Differential diagnosis and treatment of psychiatric disorders in children and adolescents with epilepsy. Epilepsy and Behavior 2004; 5(Suppl 3):10-17.
104. Austin JK, Dunn DW, Johnson CS, Perkins SM. Behavioral issues involving children and adolescents with epilepsy and the impact on their families: recent research data. Epilepsy and Behavior 2004; 5(Suppl 3):33-41.
105. Kanner AM, Dunn DW. Diagnosis and management of depression and psychosis in children and adolescents with epilepsy. J Child Neurol 2004; 19 (Suppl 1):S65-S72.
106. Fastenau PS, Shen J, Dunn DW, Perkins SM, Hermann BP, Austin JK. Neuropsychological predictors of academic underachievement in pediatric epilepsy: moderating roles of demographic, seizure, and psychosocial variables. Epilepsia 2004; 45: 1261-1272.
107. Austin JK, Dunn DW, Price MJ. Health and safety considerations. In: Austin D. Therapeutic Recreation: Processes and Techniques 5th Ed. Champaign IL, Sagamore Press, 2004:453-485.
108. Caplan R, Austin JK, Dunn D. Mood and anxiety disorders in pediatric epilepsy. In: Barry JJ. Ed. Mood Disorders in Epilepsy: Bridging the Gap between Neurology and Psychiatry. [CME enduring material sponsored by American Epilepsy Society and IntraMed Scientific Solutions] 2005: 45-58.
109. Kronenberger WG, Dunn DW. Conversion disorders. In: Maria BL. Current Management in Child Neurology 3rd Ed. Hamilton, Ontario, B C Decker Inc, 2005:450-455.
110. Kronenberger WG, Mathews VP, Dunn DW, Wang Y, Wood EA, Larsen JJ, Rembusch ME, Lowe MJ, Giauque AL, Lurito JT. Media violence exposure in aggressive and control adolescents: differences in self- and parent-reported exposure to violence on television and in video games. Aggressive Behavior 2005; 31: 201-216.
111. Kronenberger WG, Mathews VP, Dunn DW, Wang Y, Wood EA, Giauque AL, Larsen JJ, Rembusch ME, Lowe MJ, Li T. Media violence exposure and executive functioning in aggressive and control adolescents. J Clin Psychol 2005; 61:725-737.
112. Koop JI, Fastenau PS, Dunn DW, Austin JK, Neuropsychological correlates of electroencephalograms in children with epilepsy. Epilepsy Res 2005; 64:49-62.
113. Mathews VP, Kronenberger WG, Wang Y, Lurito JT, Lowe MJ, Dunn DW. Media violence exposure and frontal lobe activation measured by functional magnetic resonance imaging in aggressive and non-aggressive adolescents. J Comput Assist Tomogr 2005; 29: 287-292.
114. Weiss M, Tannock R, Kratochvil C, Dunn D, Velez-Borras J, Thomason C, Tamura R, Kelsey D, Lambrecht L, Allen AJ. A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry 2005; 44: 647-655.
115. Bohnstedt, B.N., Kronenberger, W.G., Dunn, D.W., Giauque, A.L., Wood, E.A., Rembusch, M.E., & Lafata, D. Investigator ratings of ADHD symptoms during a randomized, placebo-controlled trial of atomoxetine: A comparison of parents and teachers as informants. Journal of Attention Disorders. 2005; 8: 153-159.
116. Dunn DW, Kronenberger W. Attention deficit hyperactivity disorder and attentional problems in children with temporal lobe epilepsy. In: Arzimanoglou A, Aldenkamp A, Cross H, Lassonde M, Moshé SL, Schmitz B, eds. Cognitive Dysfunction in Children with Temporal Lobe Epilepsy. Surrey UK, John Libbey Eurotext, 2005; 31-46.
117. Li T, Mathews VP, Wang Y, Dunn D, Kronenberger W. Adolescents with disruptive behavior disorder investigated using an optimized MR diffusion tensor imaging protocol. Ann New York Acad Sci 2005; 1064: 184-192.
118. Allen AJ, Kurlan RM, Gilbert DL, Coffey BJ, Linder SL, Lewis DW, Winner PK, Dunn DW, Dure LS, Sallee FR, Milton DR, Mintz MI, Ricardi RK, Erenberg G, Layton LL, Feldman PD, Kelsey DK, Spencer TJ. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 2005; 65: 1941-1949.
119. Dunn DW, Kronenberger WG. Childhood epilepsy, attention problems, and ADHD: review and practical considerations. Seminars in Pediatric Neurology 2005; 12: 222-228.
120. Dunn DW, Austin JK. Epilepsy. In: Bear GG, Minke KM. Eds. Children’s Needs III: Development, Prevention, and Intervention. National Association of School Psychologists Publications. Bethesda MD, 2006, pp. 885-896.
121. Warren M, Dunn DW, Rushton JL. Outcome measures of triple board graduates: 1991-2003. J Am Acad Child Adolesc Psychiatry 2006; 45: 700-708.
122. Sokol DK, Chen D, Farlow MR, Dunn DW, Maloney B, Zimmer JA, Lahiri DK. High levels of Alzheimer beta-amyloid precursor protein in children with severely autistic behavior and aggression. J Child Neurol 2006; 21: 444-449.
123. Doescher JS, deGrauw TJ, Musick BS, Dunn DW, Kalnin AJ, Egelhoff JC, Byars AW, Mathews VP, Austin JK. Magnetic resonance imaging (MRI) and electroencephalographic (EEG) findings in a cohort of normal children with newly diagnosed seizures. J Child Neurol 2006; 21: 490-495.
124. Austin JK, Dunn DW, Perkins SM, Shen J. Youth with epilepsy: development of a model of children’s attitude toward their condition. Children’s Health Care 2006; 35: 123-140.
125. Gonzalez-Heydrich J, Weiss M, Connolly M, Wambera K, Jan JE, Plioplys S, Dunn DW, Kratochvil CJ. Pharmacological management of a youth with ADHD and a seizure disorder. J Am Acad Child Adolesc Psychiatry 2006; 45: 1527-1532.
126. McNelis AM, Musick B, Austin JK, Larson P, Dunn DW. Psychosocial care needs of children with recent-onset asthma. JSPN 2007; 12: 3-12.
127. Dunn DW, Kronenberger WG. Attention-deficit hyperactivity disorder, attention problems, and epilepsy. In: Ettinger AB, Kanner AM, Eds. Psychiatric Issues in Epilepsy, 2nd Ed. Philadelphia, Lippincott Williams & Wilkins, 2007, pp.272-285.
128. McNelis AM, Dunn DW, Johnson CS, Austin JK, Perkins SM. Academic achievement in children with new-onset seizures and asthma: a prospective study. Epilepsy Behav 2007; 10: 311-318
129. Baum KT, Byars AW, deGrauw TJ, Johnson CS, Perkins SM, Dunn DW, Bates JE, Austin JK. Temperament, family environment, and behavior problems in children with new-onset seizures. Epilepsy Behav 2007; 10: 319-327.
130. Katzenstein JM, Fastenau PS, Austin JK, Dunn DW, Bigatti SM, Johnson KE. Teacher’s assessments of the academic performance of children with epilepsy. Epilepsy Behav 2007; 10: 426-431.
131. Wernicke JF, Holdridge KC, Jin L, Edison T, Zhang S, Bangs ME, Allen AJ, Ball S, Dunn D. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine. Dev Med Child Neurol 2007; 49: 498-502.
132. Byars AW, deGrauw TJ, Johnson CS, Fastenau PS, Perkins SM, Egehoff JC, Kalnin A, Dunn DW, Austin JK. The association of MRI findings and neuropsychological functioning after the first recognized seizure. Epilepsia 2007; 48: 1067-1074.
133. Kronenberger WG, Giauque AL, Lafata DE, Bohnstedt BN, Maxey LE, Dunn DW. Quetiapine addition in methylphenidate treatment-resistant adolescents with comorbid attention-deficit/hyperactivity disorder, conduct/oppositional-defiant disorder, and aggression: a prospective open-label study. J Child Adolesc Psychopharmacol. 2007; 17: 334-347.
134. Kronenberger WG, Giauque AL, Dunn DW. Development and validation of the outburst monitoring scale for children and adolescents. J Child Adolesc Psychopharmacol 2007; 17: 511-526.
135. Plioplys S, Dunn DW, Caplan R. 10-year research update review: psychiatric problems in children with epilepsy. J Am Acad Child Adolesc Psychiatry 2007; 46: 1389-1402.
136. Spencer T, Kratochvil C, Sangal RB, Saylor K, Bailey C, Dunn D, Geller D, Casat C, Lipetz R, Jain R, Newcorn J, Ruff D, Feldman P, Furr A, Allen AJ. Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment. J Child Adolesc Psychopharmal 2007; 17: 689-699.
137. Patel H, Scott E, Dunn D, Garg B. Non-epileptic seizures in children. Epilepsia 2007; 48: 2086-2092.
138. Carlson GA, Dunn D, Kelsey D, Ruff D, Ball S, Ahrbecker L, Allen AJ. A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatry Ment Health 2007; 1:10 doi: 10.1186/1753-2000-1-10
139. Caplan R, Gillberg C, Dunn DW, Spence SJ. Psychiatric disorders in children. In Engel J, Pedley T. Epilepsy: A Comprehensive Textbook. 2nd Ed. Philadelphia, Lippincott Williams & Wilkins, 2007, pp 2179-2193.
140. Dunn DW, Austin JK. Psychiatric aspects of epilepsy in children. In: Schachter SC, Holmes GL, Trenité DG, Eds. Behavioral Aspects of Epilepsy. Principles and Practice. New York, Demos, 2008, pp 349-354.
141. Austin JK, Dunn DW. Academic achievement in children and adolescents with epilepsy. In: Schachter SC, Holmes GL, Trenité DG, Eds. Behavioral Aspects of Epilepsy. Principles and Practice. New York, Demos, 2008, pp 397-401.
142. Salpekar JA, Dunn DW. Psychiatric and psychosocial consequences of pediatric epilepsy. Sem Pediatr Neurol 2007; 14: 181-188.
143. Spencer TJ, Sallee FR, Gilbert DL, Dunn DW, McCracken JT, Coffey BJ, Budman CL, Ricardi RK, Leonard HL, Allen AJ, Milton DR, Feldman PD, Kelsey DK, Geller DA, Linder SL, Lewis DW, Winner PK, Kurlan RM, Mintz M. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. J Atten Disord. 2007: Oct 12 [Epub ahead of print], 2008; 11: 470-481.
144. Fastenau PS, Shen J, Dunn DW, Austin JK. Academic underachievement among children with epilepsy: proportion exceeding criteria for learning disability and relationship to seizure variables. J Learning Disabilities 2008; 41: 195-207.
145. Jones JE, Austin JK, Caplan R, Dunn D, Plioplys S, Salpekar J. Psychopathology in children and adolescents with epilepsy. Pediatrics in Review 2008; 29: e9-e14.
146. Kalapatapu R, Dunn DW. Childhood-onset schizophrenia and other psychoses. Emedicine,
Pediatrics (an on-line textbook), Updated Mar 10, 2008.
147. Barry JJ, Ettinger AB, Friel P, Gilliam, Harden CL, Hermann B, Kanner AM, Caplan R, Plioplys S, Salpekar J, Dunn D, Austin J, Jones J. Consensus statement: the evaluation of people with epilepsy and affective states. Epilepsy Behav 2008: 13, Supplement 1, S1-S29.
148. Rothner AD, Dunn DW. Headaches in children and adolescents. In Walker AM, Kaufman DM, Pfeffer CR, Solomon GE (Eds) Child and Adolescent Neurology for Psychiatrists. Philadelphia, Wolters Kluwer /Lippincott Williams & Wilkins 2008, pp 151-170.
149. Byars AW, Byars KC, Johnson CS, deGrauw TJ, Fastenau PS, Perkins SM, Austin JK, Dunn DW. The relationship between sleep problems and neuropsychological functioning in children with first recognized seizures. Epilepsy Behav 2008; 13: 607-613.
150. Austin JK, Shore CP, Dunn DW, Johnson CS, Buelow JM, Perkins SM. Development of the parent response to child illness (PRCI) scale. Epilepsy Behav 2008; 13: 662-669.
151. Kanner AM, Brown MI, Caplan R, Dunn DW, Gilliam F, Meador. Epilepsy-related depression: overlooked, undertreated [invited, non-referred review]. Neurology Reviews, supplement. Sep 2008: 6-20.
152. Kalnin AJ, Fastenau PS, deGrauw TJ, Musick BS, Perkins SM, Johnson CS, Mathews VP, Egelhoff JC, Dunn DW, Austin JK. MR imaging findings in children with first recognized seizure. Pediatric Neurology 2008; 39: 404-414.
153. Arthur TM, deGrauw TJ, Johnson CS, Perkins SM, Kalnin A, Austin JK, Dunn DW. Seizure recurrence risk following a first seizure in neurologically normal children. Epilepsia 2008; 49: 1950-1954.
154. Dunn DW, Kronenberger WG. Is ADHD in epilepsy the expression of a neurological disorder? In: Kanner A, Schachter SC. Psychiatric Controversies in Epilepsy. San Diego, Academic Press, 2008, pp 141-152.
155. Patel H, Dunn DW. Epilepsies in children, chapter 38. In: Biller J. Practical Neurology 3rd Edition, Philadelphia, Wolters Kluwer/Lippincott Williams & Wilkins, 2009, pp 491-510.
156. Kronenberger WG, Dunn DW. Conversion reaction. In: Maria BL, Editor. Current Management in Child Neurology, 4th Edition. Shelton, CT: BC Decker Inc, 2009, pp 544-550.
157. Wang Y, Mathews VP, Kalnin AJ, Mosier KM, Dunn DW, Saykin AJ, Kronenberger WG. Short term exposure to a violent video game induces changes in frontolimbic circuitry in adolescents. Brain Imaging and Behavior, 2009; 3: 38-50. DOI 10.1007/s11682-008-9058-8
158. Dunn DW, Austin JK, Perkins. Prevalence of psychopathology in children with epilepsy: categorical and dimensional measures. Dev Med Child Neurol 2009; 51: 364-372.
159. Austin JK, Dunn DW. Behavioral comorbidities in children with epilepsy. In: Schwartzkroin PA, Ed. Encyclopedia of Basic Epilepsy Research, Vol. 1, Oxford, Academic Press, 2009, pp 151-155.
160. Austin JK, Dunn DW, Price MJ. Health and safety considerations. In: Austin D. Therapeutic
Recreation: Processes and Techniques 6th Ed. Champaign IL, Sagamore Press, 2009, pp 455-489.
161. Caplan DA, Austin JK, Dunn DW. Epilepsy. In: O’Donohue WT, Tolle LW, Eds. Behavioral Approaches to Chronic Disease in Adolescence: A Guide to Integrative Care. Heidelberg, Springer, 2009, pp. 143-154.
162. Dunn DW. Neuropsychiatric comorbidities with epilepsy in children and adolescents. In: Wheless JW, Willmore LJ, and Brumback RA, Eds. Advanced Therapy in Epilepsy. Shelton, CT, People’s Medical Publishing House, 2009, pp. 423-429.
163. Fastenau PS, Johnson CS, Perkins SM, Byars AW, deGrauw TJ, Austin JK, Dunn DW. Neuropsychological status at seizure onset in children: risk factors for early cognitive deficits. Neurology, 2009; 73: 526-534.
164. Caplan R, Dunn DW, Kanner AM. Psychiatric comorbidities in epilepsy: comorbidities in children with epilepsy [invited, non-referred]. Counseling Points 2009; 1 (number 2); 1-15.
165. Salpekar JA, Plioplys S, Siddarth P, Bursch B, Shaw RJ, Asato MR,
LaFrance WC, Weisbrot DM, Dunn DW, Austin JK, Olson DM, Caplan R. Pediatric psychogenic nonepileptic seizures: a study of assessment tools. Epilepsy Behav 2010; 17: 50-55.
166. Baum KT, Byars AW, deGrauw TJ, Dunn DW, Bates JE, Howe SR, Chiu CP, Austin JK. The effect of temperament and neuropsychological functioning on behavior problems in children with new-onset seizures. Epilepsy Behav 2010; 17: 467-473.
167. Kledzik AM, Dunn DW. Treatment of attention deficit hyperactivity disorder in children with medical comorbidities. Psychopharm Rev 2010; 45 (7): 49-55.
168. Farmer K, Dunn DW, Scott E. Psychosocial factors in childhood and adolescent migraine. Seminars in Pediatric Neurology 2010; 17:93-99.
169. Block SL, Williams D, Donnelly CL, Dunn DW, Saylor KE, Ruberg SJ. Post-hoc analysis: early changes in ADHD-RS items predicting longer-term response to atomoxetine in pediatric patients. Clin Pediatrics 2010; 49: 768-776.
170. Hummer, T.A., Wang, Y., Kronenberger, W.G., Mosier, K.M., Dunn, D.W., & Mathews, V.P. Short-term violent video game play by adolescents alters prefrontal activity during cognitive inhibition. Media Psychology, 2010; 13: 136-154.
171. Dunn DW. Child and adolescent psychiatry: what the future holds (editorial-special report chairman). Psychiatric Times 2010; 27: 32.
172. Austin JK, Perkins SM, Johnson CS, Fastenau PS, Byars AW, deGrauw, TJ, Dunn, DW. Self-esteem and depression symptoms in children with seizures: relationships with neuropsychological functioning and family variables over time. Epilepsia 2010; 51: 2074-2083.
173. Dunn DW, Johnson CS, Perkins SM, Fastenau PS, Byars AW, deGrauw TJ, Austin JK. Academic problems in children with seizures: relationships with neuropsychological functioning and family variables during the 3 years after onset. Epilepsy Behav 2010; 19: 455-461.
174. Kalnin AJ, Edwards CR, Wang Y, Kronenberger WG, Hummer TA, Mosier KM, Dunn DW, Mathews VP. The interacting role of media violence exposure and aggressive-disruptive behavior in adolescent brain activation during an emotional Stroop task. Psychiatric Res: Neuroimaging 2011; 192: 12-19.
175. Hummer TA, Kronenberger WG, Wang Y, Dunn DW, Mosier KM, Kalnin AJ, Mathews VP. Executive functioning characteristics associated with ADHD comorbidity in adolescents with disruptive behavior disorders. J Abnor Child Psychol 2011; 39: 11-19.
176. Patel H, Dunn DW Austin JK, Doss J, LaFrance WC, Plioplys S, Caplan R. Psychogenic nonepileptic seizures (Pseudoseizures). Pediatrics in Review 2011; 32: e66-e72.
177. Austin JK, Perkins SM, Johnson CS, Fastenau PS, Byars AW, deGrauw TJ, Dunn DW. Behavior problems in children at time of first recognized seizure and changes over the following 3 years. Epilepsy Behav 2011; 21: 373-381.
178. Rodenburg R, Wagner JL, Austin JK, Kerr M, Dunn DW. Psychosocial issues for children with epilepsy. Epilepsy and Behavior 2011; 22: 47-54.
179. Dunn DW, Kronenberger WG, Sherman E. Autistic spectrum disorder and attention deficit hyperactivity disorder in childhood epilepsy. In: Helmstaedter C, Hermann B, Lassonde M, Kahane P, Arzimanoglou A Eds. Neuropsychology in the Care of People with Epilepsy. Surrey UK, John Libbey Eurotext, 2011: 273-284.
180. Patel H, Dunn DW. Epilepsies in children, chapter 38. In: Biller J. Practical Neurology 4th Edition, Philadelphia, Wolters Kluwer/Lippincott Williams & Wilkins, 2012, pp 412-429.
181. Kledzik A, Dunn DW. The importance of screening for internalizing symptoms, inattention, and cognitive difficulties in childhood-onset myotonic dystrophy. Dev Med Child Neurol. 2012; 54: 874-875.
182. Loth A, Dunn DW. Childhood-onset schizophrenia and other psychoses. Emedicine,
Pediatrics (an on-line textbook), Updated Feb, 2012.
183. Wietecha L, Young J, Ruff D, Dunn D, Findling R, Saylor K. Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioning. Clinical Neuropharmacology. 2012; 35: 125-133.
184. Kanner AM, Schachter SC, Barry JJ, Hesdorffer DC, Mula M, Trimble M, Hermann B, Ettinger AE, Dunn D, Caplan R, Ryvlin P, Gilliam F, LaFrance C. Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav 2012; 24: 156-168.
185. Kanner AM, Schachter SC, Barry JJ, Hesdorffer DC, Mula M, Trimble M, Hermann B, Ettinger AE, Dunn D, Caplan R, Ryvlin P, Gilliam F, LaFrance C. Depression and epilepsy, pain and psychogenic non-epileptic seizures: clinical and therapeutic perspectives. Epilepsy Behav 2012; 24: 169-181.
186. Wang Y, Horst KK, Kronenberger WG, Hummer TA, Mosier KM, Kalnin AJ, Dunn DW, Mathews VP. White matter abnormalities associated with disruptive behavior disorder in adolescents with and without attention-deficit/hyperactivity disorder. Psychiatry Research: Neuroimaging 2012; 202: 245-251.
187. Buelow JM, Perkins SM, Johnson CS, Byars AW, Fastenau PS, Dunn DW, Austin JK. Adaptive functioning in children with epilepsy and learning problems. J Child Neurol 2012; 27: 1241-1249.
188. Dunn DW, Bourgeois BFD. Learning disabilities and ADHD in children with epilepsy (chapter 41). In: Duchowny M, Cross JH, Arzimanoglou A. Pediatric Epilepsy. New York, McGraw Hill, 2012: 323-329.
189. Prentkowski ED, Dunn DW. IQ level in children with epilepsy: familial, genetic, and seizure-related factors. Dev Med Child Neurol. 2013; 55: 204. (Online publication 15 Jan 2013).
190. Buelow JM, Johnson CS, Perkins SM, Austin JA, Dunn DW. Creating avenues for parent partnership (CAPP): an intervention for parents of children with epilepsy and learning problems. Epilepsy Behav 2013; 27: 64-69. .
191. McDonald BC, Hummer TA, Dunn DW. Functional imaging as a tool for understanding the comorbidities in children with epilepsy. Epilepsy Behav 2013; 26: 295-302.
192. Thorne MC, Dunn D. In Ronen GM, Rosenbaum PL. Eds. Life Quality Outcomes in Children and Young People with Neurological and Developmental Conditions: Concepts, Evidence and Practice. London, MacKeith Press, 2013. pp. 74-86.
193. Giust J, Dunn DW. Anxiety and depression in children with epilepsy. In: Arts WF, Arzimanoglou A, Brouwer OF, Camfield C, Camfield P, eds. Outcomes of Childhood Epilepsies. Surrey UK, John Libbey, 2013. pp. 225-235.
194. Levy JD, Kronenberger WG, Dunn DW. Development of a very brief measure of ADHD: the CHAOS Scale. J Attention Dis first published on August 30, 2013 as doi:10.1177/1087054713497792
195. Dunn DW, Kronenberger WG. Attention deficit (chapter 28). In Dulac O, Sarnat H, Lassonde M. Eds. Handbook of Clinical Neurology, vol. 111, 3rd Series: Paediatric Neurology. Edinburgh, Elsevier 2013: 257-261.
196. Austin, J.K., Dunn, D.W., Lien, H. Health and safety considerations. In D. Austin, Therapeutic recreation: Processes and techniques (7th Ed.) Champaign, IL: Sagamore Press 2013:417-444.
197. Northrup H, et al. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol 2013; 49: 243-254.
198. Krueger DA, et al. Tuberous sclerosis complex surveillance and management: recommendations and of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol 2013; 49: 255-265.
199. Wietecha L, Williams D, Shaywitz S, Shaywitz B, Hooper SR, Wigal SB, Dunn DW, McBurnett K.
Atomoxetine Improved Attention in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Dyslexia in 16-week, Acute, Randomized, Double-blind Trial. J Child Adolesc Psychopharmacol. 2013; 23: 605-613.
200. Byars AW, DeGrauw TJ, Johnson CS, Perkins SM, Fastenau PS, Dunn DW, Austin JK. Language and social functioning in children and adolescents with epilepsy. Epilepsy Behav 2014; 31: 167-171.
201. Karlsson C, Dunn D. Does epilepsy in childhood affect cognitive development? Dev Med Child Neurol 2014; 56: 605-606. (published online 28 Mar 2014)
202. Austin JK, Perkins SM, Dunn DW. A model for internalized stigma in children and adolescents with epilepsy. Epilepsy Behav 2014; 36: 74-79.
203. Fodstad J, Dunn DW. Screening for autism spectrum disorders in children with epilepsy: where to begin…and where to go? Dev Med Child Neurol. 2014; 56: 1038-1039. (published online 20 June 2014)
204. Dunn DW. Focusing on ADHD and attention in children with epilepsy. Epilepsy Behav 2014; 37: 308-309.
205. Hunt AD, Kronenberger WG, Dunn DW, Gibson BS, Gondoli DM. Predictors of change in short-term memory span following working memory training. Acta Neuropsychologica 2014; 12: 445-458.
206. deVries PJ, Whittemore VH, Leclezio L, Byars A, Dunn D, Ess K, Hook D, King B, Sahin M, Jansen A. Tuberous sclerosis complex associated neuropsychiatric disorders (TAND) and the TAND Checklist. Ped Neurol 2015; 52: 25-35.
207. Sikalicky AM, Rentz AM, Liu Z, Wheless JW, Pelletier CL, Dunn DW, Frost MD, Nakagawa J, Magestro M, Prestifilippo J, Pasos C. The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: results of a patient and caregiver survey. J Child Neurology, 2015; 30: 563-569 (epub 24 Mar 2014)
208. Rentz AM, Skalicky AM, Liu Z, Wheless JW, Dunn DW, Frost MD, Nakagawa J, Magestro M, Prestifilippo J. Tuberous sclerosis complex: a survey of health care resource use and health burden. Pediatric Neurology 2015; 52: 435-441.
209. 13. Hummer TA, Wang Y, Kronenberger WG, Dunn DJ, Mathews VP. (2014). The relationship of brain structure to age and executive functioning in adolescent disruptive behavior disorder. Psychiatry Research: Neuroimaging. 2015; 231: 210-217.
210. Dunn DW, Kronenberger WG. Attention deficit/hyperactivity disorder, disordered attention, and epilepsy. In: St. Louis EK, Ficker DM, O’Brien TJ, Eds. Epilepsy and the Interictal State: Co-morbidities and Quality of Life. Oxford, Wiley-Blackwell, 2015: 63-67.
211. Patel H, Dunn DW. Nonepileptic paroxysmal disorders. Chapter 42.12, Gupta P, Menon PSN, Ramji S, Lodha, Eds. Postgraduate Textbook of Pediatrics pp. 2122-2127.
212. Austin JK, Haber LC, Dunn DW, Shore CP, Johnson CS, Perkins SM. Children with new onset seizures: A prospective study of parent variables, child behavior problems, and seizure occurrence. Epilepsy Behav 2015; 53: 73-77.
213. Rentz AM, Skalicky AM, Pashos CL, Liu Z, Magestro M, Pelletier CL, Prestifilippo JA, Nakagawa J, Frost MD, Dunn DW, Wheless JW. Caring for children with tuberous sclerosis: what is the physical and mental health impact on caregivers? J Child Neurol 2015; 30: 1574-1581. epub 2 Apr 2015)
214. Dunn DW, Kronenberger WS. Attention, executive function, and attention deficit hyperactivity disorder (chapter 13). Mula M (Ed). Neuropsychiatric Symptoms of Epilepsy. Springer, 2016, pp. 213-234.
215. Williams AE, Giust JM, Kronenberger WG, Dunn DW. Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges. Neuropsychiatric Disease and Treatment 2016: 12: 287-296.
216. Besag F, Aldenkamp A, Caplan R, Dunn DW, Gobbi G, Sillanpää M. Preface. Psychiatric and behavioural disorders in children with epilepsy (ILAE Task Force). Epileptic Disorders. 2016; 18 (Supplement 1): S1.
217. Sillanpää M, Besag F, Aldenkamp A, Caplan R, Dunn DW, Gobbi G.The epidemiology of psychiatric disorders in children with epilepsy. Epileptic Disorders. 2016; 18 (Supplement 1): S2-S7.
218. Besag F, Gobbi G, Caplan R, Sillanpää M, Aldenkamp A, Dunn DW. Epilepsy and ADHD. Epileptic Disorders. 2016; 18 (Supplement 1): S8-S15.
219. Besag F, Aldenkamp A, Caplan R, Dunn DW, Gobbi G, Sillanpää M. Epilepsy and autism. Epileptic Disorders. 2016; 18 (Supplement 1): S16-S23.
220. Dunn DW, Besag F, Caplan R, Aldenkamp A, Gobbi G, Sillanpää M. Epilepsy, anxiety and depression in children. Epileptic Disorders. 2016; 18 (Supplement 1): S24-S30.
221. Besag F, Caplan R, Aldenkamp, Dunn DW, Gobbi G, Sillanpää M. Epilepsy and psychosis in children and teenagers. Epileptic Disorders. 2016; 18 (Supplement 1): S31-S36.
222. Besag F, Gobbi G, Aldemkamp A, Caplan R, Dunn DW, Sillanpää M. Behavioural and psychiatric disorders associated with childhood epilepsy syndromes. Epileptic Disorders. 2016; 18 (Supplement 1): S37-S48.
223. Besag F, Gobbi G, Aldemkamp A, Caplan R, Dunn DW, Sillanpää M. Subtle behavioural and cognitive manifestations of childhood epilepsy. Epileptic Disorders. 2016; 18 (Supplement 1): S49-S54.
224. Aldenkamp A, Besag F, Gobbi G, Dunn DW, Sillanpää M. Adverse behavioural effects of antiepileptic drugs in children. Epileptic Disorders. 2016; 18 (Supplement 1): S55-S67.
225. Besag F, Caplan R, Aldenkamp A, Dunn DW, Gobbi G, Sillanpää M. Behavioural effects of epilepsy surgery. Epileptic Disorders. 2016; 18 (Supplement 1): S68-S76.
226. Besag F, Aldenkamp A, Caplan R, Dunn DW, Gobbi G, Sillanpää M. When should pharmacotherapy for behavioural/psychiatric disorders in children with epilepsy be prescribed? Epileptic Disorders. 2016; 18 (Supplement 1): S77-S86.
227. Salpekar J, Dunn DW. Chapter 5: The role and limits of behavioral and psychiatric evaluation. In Arzimanoglou A, Cross JH, Gaillard WD, Holthausen H, Jayakar P, Kahane P, Mathern G. (Eds). Pediatric Epilepsy Surgery. Surrey UK, John Libbey, 2016; pp 51-59.
228. Dunn DW, Salpekar JA. Chapter 146. Psychosocial outcomes following seizure surgery. In Arzimanoglou A, Cross JH, Gaillard WD, Holthausen H, Jayakar P, Kahane P, Mathern G. (Eds). Pediatric Epilepsy Surgery. Surrey UK, John Libbey, 2016; pp 515-521.
ABSTRACTS AND LETTERS:
1. Hlinak L, Dunn DW, Shapira E. Muscular form of glycogenosis type II. Amer J Human Genetics 31:73A, 1979.
2. Dunn DW, Ellison J. Anterior spinal artery syndrome during the postpartum period. Arch Neurol 38:263, 1981.
3. Beckerman R, Meltzer J, Dunn DW, Sola A, Ellis M. Brainstem auditory evoked responses (BAER) in infants with congenital alveolar hypoventilation syndrome. Ped Research 15:703, 1981.
4. Dunn DW, Reynolds J. Neonatal withdrawal symptoms following maternal addiction to pentazocine and tripelennamine. Child Neurology Society, 1981 (abstract #104).
5. Dunn DW, Wilensky M. Median and ulnar nerve palsies following infiltration of intravenous fluids.
South Med J 77:1345, 1984.
6. Dunn DW. CT in ceroid lipofuscinosis. Neurology 36(Suppl 1):114, 1986.
7. Edwards MK, Dunn DW. MRI of cortical hamartomas in the phacomatoses. Scientific Program of the Symposium Neuroradiologicum, Stockholm, Sweden, 1986.
8. Dunn DW, Purvin VA, Edwards M. MRI and cerebral venous thrombosis. Child Neurology Society, 1986 (abstract #213).
9. Dunn DW. Relapse of meningitis due to cerebral damage. Child Neurology Society, 1986 (abstract #214).
10. Dunn DW. Status epilepticus in childhood. Child Neurology Society, 1986 (abstract #215).
11. Dunn DW. When seizures are caused by carbamazepine. A reply. Contemporary Pediatrics 4:22-28, 1987.
12. Purvin VA, Dunn DW. Caffeine and the benign encephalopathy of pregnancy. Acta Neurol Scand 75:76-77, 1987.
13. Dunn DW. Status epilepticus in children: etiology, clinical features, and outcome. Neurology 37 (Suppl l):147, 1987.
14. Dunn DW. Imaging studies and EEG in childhood degenerations. Neurology 1988; 38:508-9.
15. Dunn DW, Roos KL. MRI evaluation of learning disability in neurofibromatosis. Neurology 1988; 38(Suppl 1):282.
16. Dunn DW, Pascuzzi RM, Passo M, DeVivo DC. CNS white matter abnormalities in congenital muscular dystrophy. Neurology 1988; 38(Suppl 1):293.
17. Dunn DW. Neurofibromatosis in children. Ann Neurol 1988; 24:306.
18. Dunn DW. Review of Hopkins (Ed.). Headache: problems in diagnosis and management. Neurofibromatosis 1988; 1:356-7.
19. Dunn DW. Review of DiRocco C, Vigevano F. Neurologic emergencies in infancy and childhood. Neurology 1989; 39:752.
20. Dunn DW, Parekh HV. Theophylline and status epilepticus in children. Neuropediatric 1989; 20:115.
21. Parekh HV, Dunn DW, Ackerman V. Theophylline-induced seizures. Ann Neurol 1989; 26:457.
22. Dunn DW. Review of Weisberg L, Nice C. Cerebral computed tomography. Neurofibromatosis 1989; 2:190-191.
23. Parekh HV, Dunn DW. Infantile spasm. Ann Neurol 1990; 28:473-4.
24. Dobyns WB, Pavone L, Curatolo P, Rizzo R, Micali G, Incorpora G, Garg BP, Dunn DW. Epidermal nevus syndrome: a neurological variant with hemimegalencephaly, gyral malformation, mental retardation, seizures, and facial hemihypertrophy. Ann Neurol 1990; 28:428.
25. Austin JK, Dunn DW, Levstek DA. First seizures: concerns and needs of parents and children. Epilepsia 1993; 34: Suppl 6, 24.
26. Austin JK, Dunn DW, Huster GR. Childhood epilepsy: follow-up of adaptation in adolescence. Epilepsia 1994; 35: Suppl 8, 101.
27. Dunn DW, Austin JK, Huster GR. Behavior problems in children with new-onset epilepsy. Epilepsia 1994; 35: Suppl 8, 108.
28. Austin JK, Dunn DW, Huster GR. Differences in quality of life ratings among adolescents, parents, and teachers. Epilepsia 1995; 36: S190.
29. Austin JK, Dunn DW, Huster GR. Factors predicting self-concept in youth with epilepsy. Epilepsia. 1995; 36: Suppl 4, 92.
30. Dunn DW, Austin JK, Huster GR. Family response to first seizures in children. Epilepsia 1995; 36: Suppl 4, 103.
31. Austin JK, Dunn DW, Huster GR. Family factors associated with change in behavior problems in youth with epilepsy. Epilepsia. 1995; 36: Suppl 4, 137.
32. Petti TA, Adinamis A, Nurnberger J, Dunn D, Small J. Levonorgestrel and psychiatric disorder: a reply. J Am Acad Child Adolesc Psychiatry 1996; 35:558-559.
33. Austin JK, Dunn D, Huster G. Factors related to mental health problems in youth with epilepsy. Scientific Proceedings of the Annual Meeting, American Academy of Child and Adolescent Psychiatry 1996; 12:45.
34. Austin JK, Dunn DW, Rose DF, McNelis AM, Olson K, Huster GR. Pediatric epilepsy: assessment of psychosocial care. Epilepsia 1996; 37: Suppl 5, 11.
35. Dunn DW, Austin JK, Huster GR. Factors related to depression in adolescents with epilepsy. Epilepsia 1996; 37: Suppl 5, 120.
36. Austin JK, Dunn DW, Huster GA. Behaviour problems in new onset epilepsy. Epilepsia 1997; 38: Suppl 3, 164.
37. Dunn DW. Teaching counseling in a third world country. Scientific Proceedings of the Annual Meeting, American Academy of Child and Adolescent Psychiatry/ Canadian Academy of Child Psychiatry 1997; 13:22.
38. Dunn DW, Austin JK, Huster GA, Rose DF, Creasy K, Willis JK. Assessment of behavior in children with new-onset seizures. Epilepsia 1997; 38: Suppl 8, 134.
39. Austin JK, Huster GA, Dunn DW, Huberty TJ. Academic achievement in children with epilepsy or asthma. Epilepsia 1997; 38: Suppl 8, 234.
40. Austin JK, Dunn DW, Huster GA. Factors related to change in behavior problems in youth with epilepsy. Epilepsia 1998; 39: Suppl 6, 217.
41. Dunn DW, Austin JK, Huster GA, Rose DF, Creasy K. Teacher assessment of behavior in children with new-onset seizures. Epilepsia 1998; 39: Suppl 6, 239.
42. Fastenau PS, Austin JK, Dunn DW, Huster GA. The role of neuropsychological dysfunction in academic underachievement among children with chronic epilepsy. Epilepsia 1999; 40 (Suppl 7): 43.
43. Dunn DW, Austin JK, Huster GA, Rose DF, Harezlak J. Which children with new-onset seizures are at risk for behavioral problems? Epilepsia 1999; 40 (Suppl. 7): 56.
44. Austin JK, Dunn DW, Huster GA, Rose DF, Harezlak J. Correlates of behavior problems in children with new-onset seizures. Epilepsia 1999 (Suppl 7): 75.
45. Fastenau PS, Austin JK, Dunn DW, Huster GA. Relationship between neuropsychological functioning and behavior problems in chronic epilepsy. J International Neuropsychological Soc 2000; 6:228.
46. Koop JI, Fastenau PS, Austin JK, Dunn DW, Huster GA. Neuropsychological correlates of electroencephalograms in children with epilepsy. J International Neuropsychological Society 2000; 6:227.
47. Powrozek TA, Fastenau PS, Austin JK, Dunn DW, Huster GA. Presence of cognitive impairments in children with prior unrecognized seizures. J International Neuropsychological Soc 2000; 6:227-228.
48. Ventura TG, Fastenau PS, Austin JK, Dunn DW, Huster GA. Sociodemographic factors in treatment adherence for pediatric epilepsy. J International Neuropsychological Soc 2000; 6:228.
49. Dunn D. Shame and guilt in childhood epilepsy. J Watch Neurol 2000; 2:62.
50. McNelis AM, Austin JK, Dunn DW, Creasy F, Rose DF. Academic achievement in children with new-onset epilepsy. Epilepsia 2000; 41(Suppl 7): 238.
51. Dunn DW, Austin JK, Harezlak J, Ambrosius W. Attention deficit hyperactivity disorder and chronic epilepsy in childhood. Epilepsia 2000; 41(Suppl 7): 239.
52. Austin JK, Dunn DW, Harezlak J, McNelis A, Ambrosius W. Informant agreement in behavior ratings of children with epilepsy. Epilepsia 2000; 41(Suppl 7): 239.
53. Dunn DW, Austin J, Harezlak J, Ambrosius W. Behavioral problems in childhood epilepsy. Scientific Proceedings of the 47th Annual meeting of the American Academy of Child and Adolescent Psychiatry.
2000; 16:134.
54. Dunn DW, Wernicke JF, Faries D, Heiligenstein JH, Allen AJ, Laws H, Michelson D. Efficacy of atomoxetine in placebo-controlled pediatric attention-deficit hyperactivity disorder trials. Ann Neurol 2001; 50(Suppl 1): S96.
55. Wernicke JF, Dunn D, Faries DE, Heiligenstein JH, Kelsey DK, Kendrick KL, Michelson D. Safety of atomoxetine in placebo-controlled pediatric attention-deficit hyperactivity disorder trials. Ann Neurol 2001; 50(Suppl 1): S123-S124.
56. Dunn DW, Austin JK, Harezlak J, Perkins S, Ambrosius WT. Do behavioral problems vary by recurrence of seizures? Epilepsia 2001; 42(Suppl 7): 159-160.
57. Koop JI, Fastenau PS, Austin JK, Dunn DW. Behavioral correlates of electroencephalograms in children with epilepsy. Epilepsia 2001; 42(Suppl 7): 160.
58. McNelis AM, Austin JK, Dunn DW, Shore CP, Musick BS, Huster GA. Development and preliminary study of Be Seizure Smart: a family seizure-management program. Epilepsia 2001; 42 (Suppl 7): 287.
59. Austin JK, Dunn DW, Harezlak J, Ambrosius WT, Hale B, Perkins S. Is psychosocial care related to self-concept and depression in adolescents with epilepsy? Epilepsia 2001; 42 (Suppl 7): 299-300.
60. Wernicke JF, Fouche DS, Spencer T, Dunn D, Faries DE, Kelsey DK, Heiligenstein JH, Michelson D. Atomoxetine in the treatment of children with ADHD: a randomized, placebo-controlled dose-response study. Eur Neuropsychopharmacol 2001; 11:S319-S320.
61. Wernicke JF, Fouche DS, Spencer T, Dunn D, Faries DE, Kelsy DK, Heiligenstein JH, Michelson D. Safety of atomoxetine in pediatric patients treated for ADHD. Eur Neuropsychopharmacol 2002; 11:S319.
62. Woodrome SE, Fastenau PS, Dunn DW, Austin JK. Auditory-verbal working memory and reading in children with chronic epilepsy. J Internat Neuropsychol Soc 2002; 8:302.
63. Wang Y, Mathews VP, Lurito JT, Lowe MJ, Dzemidzic M, Phillips MD, Kronenberger W, Dunn D. Adolescents with disruptive behavior disorder have different frontal lobe fMRI activation patterns as compared to control subjects. Proceedings of the International Society for Magnetic Resonance in Medicine 10th Scientific Meeting, 2002, p.128.
64. Wang Y, Mathews VP, Lowe MJ, Dzemidzic M, Lurito JT, Phillips MD, Kronenberger W, Dunn D. Retrospective motion correction of 3D EPI fMRI during go-no-go task allows robust BOLD signal detection. Proceedings of the International Society for Magnetic Resonance in Medicine 10th Scientific Meeting, 2002, p.222.
65. Wang Y, Mathews V, Lowe M, Dzemidzic M, Lurito J, Phillips M, Kronenberger W, Dunn D. BOLD signal detection using 3D EPI fMRI during go-no-go task. Proceedings of the 8th International Conference on Functional Mapping of the Human Brain, 2002, paper 10061.
66. Li T-Q, Mathews V, Wang Y, Kronenberger W, Dunn D. A DTI study of adolescents with disruptive behavior disorder. Proceedings of the 8th International Conference on Functional Mapping of the Human Brain, 2002, paper 10069.
67. Wang Y, Mathews V, Lurito J, Lowe M, Dzemidzic M, Phillips M, Kronenberger W, Dunn D. fMRI frontal lobe activation patterns of adolescents with disruptive behavior disorder as compared to control subjects. Proceedings of the 8th International Conference on Functional Mapping of the Human Brain. 2002, paper 20305.
68. Dunn D, Michelson D, Allen AJ, Kelsey D, Wernicke JF. Once-daily atomoxetine treatment for children and adolescents with attention-deficit/hyperactivity disorder. Ann Neurol 2002; 52 (Suppl 1): S116.
69. Doescher JS, Doescher D, Holder D, Austin J, Dunn DW, Mathews V, Egelhoff J, deGrauw T. Correlation of magnetic resonance imaging abnormalities and electroencephalogram patterns in healthy 6- to 14-year old children with new-onset seizures. Ann Neurol 2002; 52 (Suppl): S147.
70. Byars AW, deGrauw TJ, Caffrey HH, Fastenau PS, Egelhoff JC, Mathews VP, Dunn DW, Austin JK. Neuropsychological findings at first recognized seizure: comparison of children with and without abnormal magnetic resonance imaging. Epilepsia 2002; 43 (Suppl 7): 68.
71. Dunn DW, Austin JK, Perkins SM, Spencer N. Are sleep disruption and behavioral problems related in children with epilepsy? Epilepsia 2002; 43 (Suppl 7): 69.
72. Fastenau PS, Caffrey HH, Byars AW, Austin JK, Dunn DW, Perkins SM. Neuropsychological functioning at first recognized seizure: comparison with sibling controls and effects of prior unrecognized seizures. Epilepsia 2002; 43 (Suppl 7): 70.
73. Koop JI, Fastenau PS, McCall TJ, Dunn DW, Austin JK. Degree of sleep attained during EEG as a moderator of the relationship between spike-wave discharges and neuropsychological performance. Epilepsia 2002; 43 (Suppl 7): 71.
74. Austin JK, Dunn DW, Caffrey HH, Perkins SP, McNelis AM. Recurrent seizures and teachers’ ratings of behavior problems. Epilepsia 2002; 43 (Suppl 7): 120.
75. Buelow JM, Austin JK, Perkins SP, Shen J, Dunn DW, Fastenau PS. The interaction of gender and IQ in behavior and self-concept in children with epilepsy. Epilepsia 2002; 43 (Suppl 7): 120-121.
76. McNelis AM, Austin JK, Huberty TJ, Dunn DW. Factors associated with academic achievement in children with recent-onset seizures. Epilepsia 2002; 43 (Suppl 7): 224.
77. Allen AJ, Wernicke J, Dunn D, Kratochvil C, West S, Casat C, Harder D, Faries D, Laws H, Kelsey DK, Thomasson H, Heiligenstein JH, Potter WZ, Michelson D. Safety and efficacy of atomoxetine in pediatric CYP2D6 extensive vs. poor metabolizers. Biol Psychiatry 2002; 51:37S.
78. Koop JL, Fastenau PS, McCall TJ, Dunn DW, Austin JK. Sleep as a moderator of the relationship between spike-wave discharges and behavior. J Internat Neuropsychol Soc. 2003; 9:276-277.
79. Lewis D, Linder S, Kurlan R, Winner P, Dunn D, Sallee FR, Dure L, Erenberg G, Mintz M, Milton D, Schuh K, Allen AJ, Kelsey D. Atomoxetine for the treatment of attention deficit hyperactivity disorder and comorbid tics in children Ann Neurol 2003;54(suppl 7): S106.
80. Dunn DW, Austin JK, Perkins SM. Sleep disruption and behavioral problems in children with new-onset seizures. Ann Neurol 2003; 54(suppl 7): S133.
81. Dunn D, Allen A, Thomason C, Zhang S, Michelson D, Kelsey D. Efficacy of atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder. Ann Neurol 2003; 54(suppl 7): S143.
82. Dunn DW. Treating mental health problems at home and at school. Epilepsia 2003; 44(Suppl. 8):31.
83. Austin JK, Dunn DW, MacLeod JS, Shen J, Perkins SM. Instruments to measure stigma in children with epilepsy and their parents: initial development and testing. Epilepsia 2003; 44 (Suppl. 9): 131.
84. Fastenau PS, Johnson CS, Byars AW, Austin JK, Dunn DW, Perkins SM. Neuropsychological functioning at first recognized seizure: comparisons between seizure types. Epilepsia 2003; 44(Suppl. 9): 236.
85. Buelow JM, Dunn DW, Austin JK, Perkins SM, Shinnar S. Development of the epilepsy syndrome severity scale-child (ESSS-C). Epilepsia 2003; 44(Suppl. 9): 304.
86. Dunn DW, Austin JK, Johnson CS, Perkins SM, McNelis AM. Academic achievement in children with new-onset seizures. Epilepsia 2003; 44(Suppl. 9): 343.
87. Dunn DW. Review of Devinsky O. Epilepsy: Patient and Family Guide. Second Edition. Psychiatric Times 2004; 21(5):77.
88. Dunn DW, Austin JK, Harezlak J, Ambrosius WT. ADHD and epilepsy in childhood: an extended abstract. Search on Epilepsy 2004; 11 (no. 1): 15-16.
89. Fastenau PS, Shen J, Dunn DW, Perkins SM, Hermann BP, Austin JK. Neuropsychological predictors of academic underachievement in pediatric epilepsy: moderating roles of demographic, seizure, and psychosocial variable. Arch Clin Neuropsychol 2004; 45(Suppl 7):352.
.
90. Dunn DW, Kronenberger WG. Efficacy of atomoxetine in the treatment of children and adolescents with ADHD. J Child Neurol 2004; 19: 536-537.
91. Dunn DW, Austin J, Perkins S, Johnson C. Behavior problems in children with new-onset seizures. Scientific Proceedings of the 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry, 2004; 31: 30.
92. McNelis AM, Austin JK, Perkins SM, Johnson CS, Dunn DW. Relationships between family variables and health condition in a new-onset sample. Epilepsia 2004; 45 (Suppl 7):238.
93. Shore SP, Austin JK, Dunn DW, Johnson CS, Perkins, SM. Relationships between family variables and child behavior problems in a new-onset sample. Epilepsia 2004; 45 (Suppl 7): 239.
94. Dunn DW, Austin JK, Johnson CS, Perkins SM. Do attention problems and internalizing problems predict seizure recurrence in children? Epilepsia 2004; 45 (Suppl 7): 351.
95. Fairbanks JM, Cunningham NC, Fastenau PS, Austin JK, Dunn DW. ADHD classification in children with chronic epilepsy: discrepancies between measures of attention and school classification. Epilepsia 2004; 45 (Suppl 7): 351.
96. Fastenau PS, Shen J, Dunn DW, Austin JK, Perkins SM. Effect of seizure control on neuropsychological performance and academic achievement over time in children with epilepsy. Epilepsia 2004; 45 (Suppl 7): 352.
97. Katzenstein JM, LeJeune BC, Fastenau PS, Austin JK, Dunn DW. Academic underachievement and access to educational services after a neuropsychological report in children with epilepsy. Epilepsia 2004; 45 (Suppl 7):354.
98. McCall TJ, Fastenau PS, Johnson KE, Dunn DW, Austin JK. Effects of duration of disorder and seizure control status on objective neuropsychological performance versus subjective self-appraisal in children with epilepsy. Epilepsia 2004; 45 (Suppl 7): 356.
99. Fastenau PS, Shen J, Dunn DW, Austin JK. Academic achievement among children with epilepsy: rates of learning disability and relationship to seizure variables. J Internat Neuropsychol Soc 2005; 11(Suppl 1):55.
100. Katzenstein JM, Mathiey LN, Fastenau PS, Austin JK, Dunn DW. Reading underachievement in children with epilepsy. J Internat Neuropsychol Soc 2005; 11(Suppl 1):55.
101. Neal TJ, Fastenau PS, Johnson KE, Dunn DW, Austin JK. Effects of duration of disorder and seizure control status on objective neuropsychological performance versus subjective self-appraisal in children with epilepsy across six cognitive domains. J Internat Neuropsychol Soc 2005; 11(Suppl 1):56.
102. Dunn DW, Turgay A, Weiss M, Dickson R, Feldman PD, Sher L, Melmed RD, Saylor K, Busner J, Ramsey JL, Allen AJ. Use of plasma concentration to guide atomoxetine doses in ADHD patients. New Research Abstracts, Annual Meeting of the American Psychiatric Association, 2005: NR 502.
103. Dunn DW. Mood disorders in children with epilepsy. Syllabus and Proceedings Summary. American Psychiatric Association 2005 Annual Meeting. p.219.
104. Dunn DW, Kronenberger WG. Treatment of attention disorders in children with epilepsy. Epilepsia 2005; 46 (Suppl 6):6.
105 Austin JK, Perkins SM, Dunn DW, Fastenau PS. Association between cognitive functioning and mental health problems in children with epilepsy. Epilepsia 2005; 46 (Suppl 6): 64-65.
106. Cunningham NC, Fastenau PS, Austin JK, Dunn DW. Seizure variables and neuropsychological outcomes in children with low IQ and epilepsy. Epilepsia 2005; 46(Suppl 8): 76.
107. Dunn DW, Fastenau PS, Austin JK, Perkins SM. Neuropsychological functioning over time in children with epilepsy. Epilepsia 2005; 46(Suppl 8): 76.
108. Fastenau PS, Johnson CS, Byars AW, Dunn DW, Austin JK, Perkins SM. Neuropsychological changes in children during the first 18 months after new onset of seizures. Epilepsia 2005; 46(Suppl 8): 76-77
109. Katzenstein JM, Fastenau PS, Austin JK, Dunn DW, Bigatti SM, Johnson KE. Teachers’ perceptions of the academic performance of children with epilepsy. Epilepsia 2005; 46(Suppl 8): 78.
110. McNutt CT, Byars AW, deGrauw TJ, Cooper EB, Austin JK, Johnson CS, Dunn DW, Perkins SM. Infant temperament and behavior problems in children with new-onset seizures. Epilepsia 2005; 46(Suppl 8): 79.
111. Dunn DW, Kronenberger WG, Giauque AL, Lafata DE, Maxey LE. Improvement in specific aggressive outbursts in adolescents with ADHD following augmentation of methylphenidate with quetiapine. New Research Abstracts. American Psychiatric Association 159th Annual Meeting. 2006, NR 649.
112. Spencer T, Sallee FR, Dunn D, et al. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. Neuropediatrics 2006; 37 (Suppl 1): S98 and 2006 AACAP Scientific Proceedings 2006; 33:166.
113. Dunn D. Problems with attention in children with epilepsy. Neuropediatrics 2006; 37 (Suppl 1): S131.
114. Wernicke JF, Chilcott KE, Edison T, Zhang S, Bangs ME, Read HA, Ruff DD, Allen AJ, Dunn D. Seizure risk with ADHD treated with atomoxetine. Neuropediatrics 2006; 37 (Suppl 1): S165.
115 Spencer TJ, Kratochvil C, Sangal R, Saylor K, Bailey C, Dunn D, Casat C, Lipetz R, Jain R, Newcorn J, Ruff D, Feldman P, Allen A. Five-year effects of atomoxetine on growth in children wit ADHD. 2006 AACAP Scientific Proceedings 2006; 33: 166.
116. Carlson GA, Dunn D, Kelsey D, Ruff D, Ball S, Ahrbecker L, Allen AJ. Safety of augmenting atomoxetine with methylphenidate in stimulant-resistant ADHD. 2006 AACAP Scientific Proceedings 2006; 33: 198.
117. Kalnin AJ, deGrauw TJ, Fastenau PS, Dunn DW, Mathews VP, Egelhoff JC, Perkins SM, Calley CS, Musick BS, Austin JK. MRI findings in children with first recognized seizure. Epilepsia 2006; 47 (Suppl S4): Ab. 1.160., 2006 Annual Meeting of the American Epilepsy Society. San Diego CA.
118. Byars AW, Byars KC, Johnson CS, Fastenau PS, Dunn DW, Austin JK. The relationship between sleep problems and cognition in children with new-onset seizures. Epilepsia 2006; 47 (Suppl S4): Ab. 1.224., 2006 Annual Meeting of the American Epilepsy Society. San Diego CA.
119. Cunningham NC, Austin JK, Dunn DW. The relationship between executive functioning and social problems in adolescents with epilepsy. Epilepsia 2006; 47 (Suppl S4): Ab.1.227, 2006 Annual Meeting of the American Epilepsy Society. San Diego CA.
120. Dunn DW, Austin JK, Johnson CS, Perkins SM. Does behavior in children improve with the treatment of seizures? Epilepsia 2006; 47 (Suppl S4): Ab.1.228, 2006 Annual Meeting of the American Epilepsy Society. San Diego CA.
121. McNelis AM, Myers JE, Austin JK, Dunn DW. Further development of a parent seizure management program: Be Seizure Smart. Epilepsia 2006; 47 (Suppl S4): Ab.2.005, 2006 Annual Meeting of the American Epilepsy Society. San Diego CA.
122. Arthur TM. deGrauw TJ, Johnson CS, Dunn DW, Austin JK. Seizure recurrence risk following a first seizure in children 6-14 years old. Epilepsia 2006; 47 (Suppl S4): Ab.2.033, 2006 Annual Meeting of the American Epilepsy Society. San Diego CA.
123. Fairbanks JM, Cunningham NC, Fastenau PS, Perkins SM, Dunn DW, Austin JK. ADHD in epilepsy: discrepant proportions between the CSI/ASI and school classification. Epilepsia 2006; 47 (Suppl S4): Ab. 2.040, 2006 Annual Meeting of the American Epilepsy Society. San Diego CA.
124. Patel H, Dunn DW, Scott E, Garg B. Nonepileptic seizures in children. Epilepsia 2006; 47 (Suppl S4): Ab. 2.052., 2006 Annual Meeting of the American Epilepsy Society. San Diego CA.
125. Dunn DW. Treatment of mood disorders in children with epilepsy. Proceedings of the 27th Annual International Epilepsy Congress. Singapore, p. 15.
126. Shore CP, Buelow JM, Austin JK, Dunn DW. Association between seizure type and prior unrecognized seizures in a sample of children presenting with a first recognized seizure. Epilepsia 2007; 48 (Suppl 6):Ab. 1.147. 2007 Annual Meeting of the American Epilepsy Society, Philadelphia PA.
127. Dunn DW, deGrauw T, Johnson C, Perkins S, Austin J. Risk factors at baseline for persistent seizures after a first recognized seizure. Epilepsia 2007; 48 (Suppl 6): Ab. 1.159. 2007 Annual Meeting of the American Epilepsy Society. Philadelphia PA.
128 Buelow JM, Shore CP, Perkins SM, Dunn DW, Austin JK. The association of child IQ to parental outcomes (mental health and response to child illness). Epilepsia 2007; 48 (Suppl 6):Ab. 1.304. 2007 Annual Meeting of the American Epilepsy Society, Philadelphia PA.
129. Augusta MB, Byars AW, Baum KT, deGrauw TJ, Johnson CS, Dunn DW, Perkins SP, Austin JK. Symptoms of depression and attitudes toward illness in children with new-onset seizures. Epilepsia 2007; 48 (Suppl 6): Ab. 1.312. 2007 Annual Meeting of the American Epilepsy Society, Philadelphia PA.
130. Fastenau PS, Johnson CS, Dunn DW, deGrauw TJ, Byars AW, Perkins SM, Austin JK. Neuropsychological correlates of EEGs at the first recognized seizure: biomarkers for current and future cognitive comorbidities. Epilepsia 2007; 48 (Suppl 6):Ab. 2.276. 2007 Annual Meeting of the American Epilepsy Society, Philadelphia PA.
131. Dunn DW, Austin JK, Johnson CS, Perkins SM. Family functioning and psychopathology in children and adolescent with epilepsy. Ab. 32.2. 2008 AACAP Scientific Proceedings. 2008; 35: 100.
132. Plioplys S, Siddarth P, Asato MR, Austin JK, Bursch B, Dunn DW, Shaw RJ, Salpekar J, Zukerman J, Caplan R. Parents of children with non-epileptic events: psychological and medical features. Ab. 4.16. 2008 AACAP Scientific Proceedings. 2008; 35: 227-228.
133. Salpekar J, Siddarth P, Asato MR, Plioplys S, Bursch B, Shaw RJ, Foster L, Dunn DW, Olson D, Zukerman J, Austin JK, Caplan R. Anxiety and somatization symptoms in pediatric non-epileptic events: a pilot study of assessment tools. Ab. 4.17. 2008 AACAP Scientific Proceedings. 2008; 35: 228.
134. Byars A, Johnson C, Fastenau P, deGrauw T, Perkins S, Austin J, Dunn D. Language and social functioning in children and adolescents with epilepsy. Epilepsia 2008; 48 (Suppl 6): abstract 1.334.
135. Fastenau P, Johnson C, Dunn D, Byars A, Perkins S, deGrauw T, Austin J. Relationship between seizure control and neuropsychological change during the first 3 years following seizure onset in children. Epilepsia 2008; 49 (Suppl 7): abstract 1.339.
136. Plioplys S, Siddarth P, Asato M, Austin J, Bursch B, Dunn D, Shaw R, Salpekar J, Zukerman J, Caplan C. Parents of children with non-epileptic events (NEE): psychological and medical profiles. Epilepsia 2008; 48 (Suppl 7): abstract 1.346
137. Buelow J, Austin J, Dunn D, Shore C, Perkins S. Development of the Parent Response to Illness Scale (PRCI) Epilepsia 2008; 49 (Suppl 7): abstract 2.008.
138. Dunn D, deGrauw T, Johnson C, Perkins S, Austin J. Relationship between seizure risk factors and mental health outcomes in children. Epilepsia 2008; 49 (Suppl 7): abstract 2.222.
139. Salpekar J, Siddarth P, Plioplys S, Asato M, Shaw R, Bursch B, Olson D, Zukerman J, Foster L, Austin J, Dunn D, Caplan R, Behavioral profiles of children with non-epileptic events versus epilepsy. Epilepsia 2008; 49 (Suppl 7): abstract 2.228.
140. Shore C, Kreutzer M, Austin J, Dunn D, Buelow J. Children with epilepsy plus ADHD symptomatology compared to children with epilepsy only: differences in self-concept, mood, and family satisfaction. Epilepsia 2008; 49 (Suppl 7): abstract 2.23
141. Buelow JM, Johnson CS, Dunn DW, Perkins SM. Satisfaction with “Creating Avenues for Parent Partnership;” an intervention for parent’s of children with epilepsy (ab. 1.007). Epilepsia 2009; 50 (suppl 11): 4.
142. Dunn DW, Johnson CS, Byars AW, deGrauw TJ, Fastenau PS, Perkins SM, Austin JK. Academic problems in children with seizures: relationships over time with neuropsychological functioning and family variables (ab. 2.283). Epilepsia 2009; 50 (suppl 11): 286.
143. Wietecha L, Qiao M, Dunn DW, Young JL, Saylor K. A double-blind, placebo-controlled trial of atomoxetine once daily for 24 weeks in adults with ADHD: impact of treatment on family functioning. 2010 AACAP Scientific Proceedings 2010; 37: 267, abstract 2.56.
144. Fastenau PS, Johnson CS, Byars AW, Perkins SM, Dunn DW, deGrauw TJ, Austin JK. Age-related vulnerability to risks for neuropsychological decline following seizure onset in school-age children (ab. 1.358). 2010, American Epilepsy Society Annual Meeting, . and Epilepsy Currents 2011; 11 (suppl 1): 160.
145. Dunn DW, Johnson CS, Fastenau PS, Byars AW, deGrauw TJ, Perkins SM, Austin JK. Are antiepileptic drugs associated with suicidal ideation in children with new-onset seizures? (ab. 3.261).
2010, American Epilepsy Society Annual Meeting, . and Epilepsy Currents 2011; 11 (suppl 1): 474-475.
146. Wietecha L, Williams D, Shaywitz S, Shaywitz B, Hooper S, Wigal SB, Dunn DW, McBurnett K. Efficacy of treatment with atomoxetine for attention in children and adolescents with ADHD and comorbid dyslexia. American Academy of Child and Adolescent Psychiatry annual meeting, Toronto, 19 Oct 2011 (Abstract 1.2), posted at
147. Dunn DW. Epilepsy and Psychopathology: Differential Diagnosis. Clinical Perspectives 11, Pediatric topics in child psychiatry: epilepsy, neurodevelopmental disorders, and gynecological health. American Academy of Child and Adolescent Psychiatry annual meeting, Toronto, 20 Oct 2011. Posted at .
148. Fastenau PS, Johnson CS, Byars AW, deGrauw TJ, Dunn DW, Austin JK. Prospective neuropsychological data from healthy siblings before and after the very first seizures. Ab 2.001. Epilepsy Currents 2012; 12 (Suppl 1): 128.
149. Gleason MM, Dunn D, Gray D, Fritsch S, Guerrero A, Kleinschmidt K, Lowenhaupt E, Ortiz-Aguayo, Sargent J, Hunt J, Myint M. Triple board training: goals and outcomes (Ab. 1.28). 2012, American Academy of Child and Adolescent Psychiatry 59th Annual Meeting.
150. Frost M, Rentz A, Pashos C, Liu J, Pelletier C, Prestifilippo J, Nakagawa J, Wheless J, Dunn D. Characteristics and burden of seizures in patients with tuberous sclerosis complex: results of a patient and caregiver survey in the US. (Ab. 2.337). 2012, American Epilepsy Society 66th Annual meeting.
151. Dunn DW, Rentz AM, Pashos CL, Skalicky A, Liu J, Pelletier C, Nakagawa JA, Frost MD, Wheless JW. Characteristics and Burden of Subependymal Giant Cell Astrocytomas (SEGAs) in Patients with Tuberous Sclerosis Complex: Results of a Patient and Caregiver Survey. (Ab. P07.016). 2013, American Academy of Neurology 65th Annual meeting.
152. Besag F, Aldenkamp A, Caplan R, Dunn D, Gobbi G, Sillanpaa M. Psychiatric disturbances in children with epilepsy (Ab. 2.018) 2014 American Epilepsy Society 67th Annual Meeting.
153. Dunn DW. Psychotic symptoms and neurologic testing. (Ab. Clinical Perspectives 5) American Academy of Child and Adolescent Psychiatry 62nd Annual Meeting, San Antonio TX. 27 Oct 2015
154. Dunn DW. The role of the neurologist in the management of psychogenic non-epileptic seizures. (Ab. Clinical Perspectives 17) American Academy of Child and Adolescent Psychiatry 62nd Annual Meeting, San Antonio TX. 28 Oct 2015
PRESENTATIONS:
1. Dunn DW. Recent changes in the treatment of seizures. Update Your Pediatrics - 1980, February 13, 1980, New, Orleans, LA.
2. Dunn DW. Psychosocial problems of epilepsy. Comprehensive Review of Psychiatry and Issues of Prevention, February 18, 1980, New Orleans, LA.
3. Dunn DW. Brain tumors. Internal Medicine Board Review, September 6, 1980, New Orleans, LA and September 12, 1981, New Orleans, LA.
4. Dunn DW. Immature and mature nervous system. American Academy Cerebral Palsy and Developmental Medicine, April 23, 1981, New Orleans, LA.
5. Dunn DW. Evaluation of the awkward child. American Academy of Pediatrics, October 31, 1981, New Orleans, LA.
6. Dunn DW. Medical management of brain abscess and cerebritis. Southern Medical Association, November 4, 1984, New Orleans, LA.
7. Dunn DW. CT in ceroid lipofuscinosis. American Academy of Neurology, April 29, 1986, New Orleans, LA.
8. Edwards MK, Dunn DW. MRI of cortical hamartomas in the phacomatoses. Symposium Neuroradiologicum, 1986, Stockholm, Sweden.
9. Dunn DW. Status epilepticus in children. American Academy of Neurology, April 7, 1987, New York City, NY.
10. Rubenstein AE, Wallace J, Aron A, Taff I, Dunn D. Neurofibromatosis: other forms. NIH Consensus Development Conference, July 13, 1987.
11. Bull MJ, Weaver DD, Dunn D. Siblings with a variant of hypochodrogenesis. DW Smith Dysmorphology Conference, August 1987, Greenwood, South Carolina.
12. Dunn DW, Roos KL. MRI evaluation of learning disability in neurofibromatosis. American Academy of Neurology, April 20, 1988, Cincinnati, OH.
13. Dunn DW, Pascuzzi RM, Passo M, DeVivo DC. CNS white matter abnormalities in congenital muscular dystrophy. American Academy of Neurology, April 20, 1988, Cincinnati, Ohio.
14. Dunn DW. Impaired coordination in neurofibromatosis type 1. Research Symposium on Neurofibromatosis, May 4, 1988, New York City, NY.
15. Dunn DW. Neurofibromatosis in children. Child Neurology Society, September 15, 1988, Halifax.
16. Dunn DW, Parekh HV. Theophylline and status epilepticus in children. European Federation of Child Neurology Societies. June 26, 1989, Prague, Czechoslovakia.
17. Roos KL, Pascuzzi RM, Dunn DW. Neurofibromatosis, Charcot-Marie-Tooth Disease, or Both? American Academy of Clinical Neurophysiology, July 1989, Boston, MA.
18. Parekh HV, Dunn DW. Ackerman V. Theophylline-induced seizures. Child Neurology Society, October 13, 1989, San Antonio, TX.
19. Dunn DW. Optic pathway glioma. Neurofibromatosis Symposium, October 14, 1989, San Antonio, TX.
20. Dunn DW. Moderator, Neurofibromatosis Symposium, October 14, 1989, San Antonio, TX.
21. Dunn DW. a. Nonepileptiform Paroxysmal Disorders of Childhood b. Therapy of Childhood Seizures c. Ataxia and the Clumsy Child d. Rett Syndrome 3. Neurodiagnostic Procedures. Co-director Neurology Course, American Academy of Pediatrics, October 22, 1989, Chicago, IL.
22. Dunn DW. Neurofibromatosis in children. New Orleans Neurological Society, November 16, 1989.
23. Dunn DW. Neurofibromatosis in Children. Illinois NF Society, September 15, 1990, Chicago.
24. Parekh H, Dunn DW. Infantile spasms. Child Neurology Society, October 19, 1990, Atlanta, Georgia.
25. Dobyns WB, Pavone L, Curatolo P, Rizzo R, Micali G, Incorpora G, Garg BP, Dunn DW. Epidermal nevus syndrome: a neurological variant with hemimegalencephaly, gyral malformation, mental retardation, seizures, and facial hemihypertrophy. Child Neurology Society, October 18, 1990, Atlanta, Georgia.
26. Austin JK, Dunn DW, Levstek DA. First seizures: concerns and needs of parents and children, American Epilepsy Society, December, 1993, Miami, Florida.
27. Dunn DW. Parenting the only child with spina bifida. Spina Bifida Association of America National Conference, June 24, 1994, Indianapolis IN.
28. Austin JK, Dunn DW, Huster GR. Childhood epilepsy: follow-up of adaptation in adolescence. American Epilepsy Society, December, 1994, New Orleans, LA.
29. Dunn DW, Austin JK, Huster, GR. Behavior problems in children with new onset epilepsy. American Epilepsy Society, December, 1994, New Orleans, LA.
30. Dunn, DW. Behavioral issues in children with TSC. NTSA Medical Education Conference, March, 1995, Dallas TX.
31. Dunn DW. Psychopharmacology for depression in adolescents. 30th Annual Indiana Child Care Conference, May, 1995, Indianapolis IN.
32. Dunn, DW. Psychosocial aspects of TSC in childhood. NTSA Medical Education Conference, June, 1995, Detroit MI.
33. Dunn DW. Pediatric uses of psychostimulants: potential for uses and abuses. American Academy of Pediatrics annual meeting, October, 1995, San Francisco CA
34. Dunn DW. Management of behavioral disorders: when Ritalin fails. American Academy of Pediatrics annual meeting, October, 1995, San Francisco CA.
35. Dunn DW. Medications to treat behavior problems in TSC. Tuberous Sclerosis Clinical Care Conference, October, 1995, Baltimore MD.
36. Austin JK, Dunn DW, Huster GR. Factors predicting self-concept in youth with epilepsy. American Epilepsy Society. December 1995, Baltimore MD.
37. Dunn DW, Austin JK, Huster GR. Family response to first seizures in childhood. American Epilepsy Society. December 1995, Baltimore MD.
38. Austin JK, Dunn DW, Huster GR. Family factors associated with change in behavior problems in youth with epilepsy. American Epilepsy Society, December, 1995, Baltimore MD.
39. Dunn DW. Management of seizure disorders during pregnancy. Neurology for the Primary Care Physician, May, 1996, Indianapolis IN.
40. Austin JK, Dunn DW, Huster G. Factors related to mental health problems in youth with epilepsy. American Academy of Child and Adolescent Psychiatry, October, 1996, Philadelphia PA.
41. Austin JK, Dunn DW, Rose DF, McNelis AM, Olson K, Huster GR. Pediatric epilepsy: assessment of psychosocial care. American Epilepsy Society, December, 1996, San Francisco CA.
42. Dunn DW, Austin JK, Huster GR. Factors related to depression in adolescents with epilepsy. American Epilepsy Society, December, 1996, San Francisco CA.
43. Dunn DW. Psychopharmacology and Tuberous Sclerosis Complex. North Atlantic Regional Conference on Tuberous Sclerosis Complex, September, 1997, Boston MA.
44. Dunn DW. Teaching Counseling in a Third World Country. American Academy of Child and Adolescent Psychiatry/ Canadian Academy of Child Psychiatry joint annual meeting, October, 1997, Toronto, Canada.
45. Dunn DW. Austin JK, Huster GA, Rose DF, Creasy K, Willis JK. Assessment of Behavior in Children with new on-set seizures. American Epilepsy Society. December, 1997, Boston.
46. Austin JK, Huster GA, Dunn, DW, Hurberty TJ. Academic Achievement in Children with Epilepsy or Asthma. American Epilepsy Society. December, 1997, Boston.
47. Dunn DW. Behavioral Issues in Pediatric Epilepsy. School of Medicine, State University of New York at Stony Brook, March 28, 1998, New York City.
48. Dunn DW. Behavioral Aspects of Tuberous Sclerosis. Advances in Neurogenetic Disorders and Tuberous Sclerosis. University of Texas Medical Branch, April 25, 1998, Galveston, Texas.
49. Dunn DW. Social and Educational Issues in TSC: panel summary. Tuberous Sclerosis Complex Consensus Conference. NIH/NTSA, July, 1998, Annapolis, Maryland
50. Austin JK, Dunn DW, Huster GA. Factors related to change in behavior problems in youth with epilepsy. American Epilepsy Society, December 1998, San Diego, California.
51. Dunn DW, Austin JK, Huster GA, Rose DF, Creasy F. Teacher assessment of behavior in children with new-onset seizures. American Epilepsy Society, December, 1998, San Diego, California.
52. Dunn DW. Psychopharmacology for Behavioral Problems in Children. Pediatrics Grand Rounds, University of Cincinnati, April 27, 1999, Cincinnati, Ohio.
53. Dunn DW. Differential diagnosis and treatment of mental illness in tuberous sclerosis. National Family Conference on Tuberous Sclerosis, July, 1999, Washington, DC.
54. Fastenau PS, Austin JK, Dunn DW, Huster GA. The role of neuropsychological dysfunction in academic underachievement among children with chronic epilepsy. American Epilepsy Society, December 1999, Orlando Florida
55. Dunn DW, Austin JK, Huster GA, Rose DF, Harezlak J. Which children with new-onset seizures are at risk for behavioral problems? American Epilepsy Society, December 1999, Orlando Florida.
56. Austin JK, Dunn DW, Huster GA, Rose DF, Harezlak J. Correlates of behavior problems in children with new-onset seizures. American Epilepsy Society, December 1999, Orlando Florida.
57. Dunn DW. TSC, ADD and disruptive behaviors – the link with epilepsy. Behaviour Disorders in Tuberous Sclerosis: Concepts and Current Research. January 2000, University of Cambridge, Cambridge, England.
58. Koop JI, Fastenau PS, Austin JK, Dunn DW, Huster GA. Neuropsychological correlates of electroencephalograms in children with epilepsy. International Neuropsychological Society, Feb 2000, Denver CO.
59. Fastenau PS, Austin JK, Dunn DW, Huster GA. Relationship between neuropsychological functioning and behavior problems in chronic epilepsy. International Neuropsychological Society, February 2000, Denver CO.
60. Powrozek TA, Fastenau PS, Austin JK, Dunn DW, Huster GA. Presence of cognitive impairments in children with prior unrecognized seizures (PURS). International Neuropsychological Society, February 2000, Denver CO.
61. Ventura TG, Fastenau PS, Austin JK, Dunn DW, Huster GA. Sociodemographic factors in treatment adherence for pediatric epilepsy. International Neuropsychological Society, February 2000, Denver CO.
62. Dunn DW. Moderator, Neurology and Epilepsy in TSC; Panel member, Problems in TSC. TSC Millennium Research Symposium 2000. September 13-15, 2000, Edinburgh Scotland.
63. Dunn DW, Austin JK, Harezlak J, Ambrosius WT. Behavioral problems in childhood epilepsy. American Academy of Child and Adolescent Psychiatry. New York, October 28, 2000.
64. Austin JK, Dunn DW, Harezlak J, McNelis A, Ambrosius W. Informant agreement in behavior ratings of children with epilepsy. American Epilepsy Society, Los Angeles, December 6, 2000.
65. Dunn DW, Austin JK, Harezlak J, Ambrosius W. Attention deficit hyperactivity disorder and chronic epilepsy in childhood. American Epilepsy Society, Los Angeles, December 6, 2000
66. McNelis AM, Austin JK, Dunn DW, Creasy F, Rose DF. Academic achievement in children with new-onset seizures. American Epilepsy Society, Los Angeles, December 6, 2000
67. Dunn DW. All that fidgets is not ADHD. Arthur B. Richter Conference, Indianapolis, April 27, 2001
68. Dunn DW, Kronenberger WK. ADHD: an update for primary care providers. 36th Annual Indiana Multidisciplinary Child Care Conference, Indianapolis, May 17, 2001.
69. Austin JK, Dunn DW. Progressive behavioral changes in children with epilepsy: cross-sectional and prospective findings, Invited presentation, Do Seizures Damage the Brain? Rovaniemi, Finland, June 30, 2001.
70. Dunn DW, Wernicke JF, Faries D, Heiligenstein JH, Allen AJ, Laws H, Michelson D. Efficacy of atomoxetine in placebo-controlled pediatric attention-deficit hyperactivity disorder trials. 30th Annual Meeting of the Child Neurology Society, Victoria, British Columbia, Canada, October 18, 2001.
71. Wernicke JF, Dunn DW, Faries DE, Heiligenstein JH, Kelsey DK, Kendrick KL, Michelson D. Safety of atomoxetine in placebo-controlled pediatric attention-deficit hyperactivity disorder trials. 30th Annual Meeting of the Child Neurology Society, Victoria, British Columbia, Canada, October 19, 2001.
72. Dunn DW. Managing the child with epilepsy-behavior and learning difficulties: psychiatric aspects. Allied Health Symposium, American Epilepsy Society, Philadelphia, December 1, 2001.
73. Dunn DW, Austin JK, Harezlak J, Perkins S, Ambrosius WT. Do behavioral problems vary by recurrence of seizures? American Epilepsy Society, Philadelphia, December 4, 2001.
74. Koop JI, Fastenau PS, Austin JK, Dunn DW. Behavioral correlates of electroencephalograms in children with epilepsy. American Epilepsy Society, Philadelphia, December 4, 2001.
75. McNelis AM, Austin JK, Dunn DW, Shore CP, Musick BS, Huster GA. Development and preliminary study of be seizure smart: a family seizure-management program. American Epilepsy Society, Philadelphia, December 5, 2001.
76. Austin JK, Dunn DW, Harezlak J, Ambrosius ST, Hale B, Perkins S. Is psychosocial care related to self-concept and depression in adolescents with epilepsy? American Epilepsy Society, Philadelphia, December 5, 2001.
77. Dunn DW. Psychopharmacology of violence and aggression. Arthur B Richter Conference in Child Psychiatry. Indianapolis, April 19, 2002.
78. Wernicke JF, Kratochvil CJ, Milton DR, Dunn DW, Spencer TJ, Heiligenstein JH, Michelson D. Long-term safety of atomoxetine in children and adolescents with ADHD. American Psychiatric Association 2002 Annual Meeting. Philadelphia, May 2002.
79. Wang Y, Mathews VP, Lowe MJ, Dzemidzic M, Lurito JT, Phillips MD, Kronenberger W, Dunn D. Retrospective motion correction of 3D EPI fMRI during go-no-go task allows robust BOLD signal detection. International Society for Magnetic Resonance in Medicine 10th Scientific Meeting, Honolulu, May 22, 2002.
80. Wang Y, Mathews VP, Lurito JT, Lowe MJ, Dzemidzic M, Phillips MD, Kronenberger W, Dunn D. Adolescents with disruptive behavior disorder have different frontal lobe fMRI activation patterns as compared to control subjects. International Society for Magnetic Resonance in Medicine 10th Scientific Meeting, Honolulu, May 24, 2002.
81. Wang Y, Mathews V, Lowe M, Dzemidzic M, Lurito J, Phillips M, Kronenberger W, Dunn D. BOLD signal detection using 3D EPI fMRI during go-no-go task. 8th International Conference on Functional Mapping of the Human Brain, Sendai, Japan, June 3, 2002.
82. Li T-Q, Mathews V, Wang Y, Kronenberger W, Dunn D. A DTI study of adolescents with disruptive behavior disorder. 8th International Conference on Functional Mapping of the Human Brain, Sendai. Japan, June 3, 2002
83. Wang Y, Mathews V, Lurito J, Lowe M, Dzemidzic M, Phillips M, Kronenberger W, Dunn D. fMRI frontal lobe activation patterns of adolescents with disruptive behavior disorder as compared to control subjects. 8th International Conference on Functional Mapping of the Human Brain. Sendai, Japan, June 6, 2002.
84. Dunn D, Michelson D, Allen AJ, Kelsey D, Wernicke JF. Once-daily atomoxetine treatment for children and adolescents with attention-deficit/hyperactivity disorder. Annual meeting of the Child Neurology Society. Washington DC, October 10, 2002.
85. Doescher JS, Doescher D, Holder D, Austin J, Dunn DW, Mathews V, Egelhoff J, deGrauw T. Correlation of magnetic resonance imaging abnormalities and electroencephalogram patterns in healthy 6- to 14-year old children with new-onset seizures. Annual meeting of the Child Neurology Society. Washington DC, October 11, 2002.
86. Byars AW, deGrauw TJ, Caffrey HH, Fastenau PS, Egehoff JC, Mathews VP, Dunn DW, Austin JK. Neuropsychological findings at first recognized seizure: comparison of children with and without abnormal MRI. Annual Meeting of the American Epilepsy Society, Seattle, December 9, 2002.
87. Dunn DW, Austin JK, Perkins SM, Spencer N. Are sleep disruption and behavioral problems related in children with epilepsy? Annual meeting of the American Epilepsy Society, Seattle, December 9, 2002.
88. Fastenau PS, Caffrey HH, Byars AW, Austin JK, Dunn DW, Perkins SM. Neuropsychological functioning at first recognized seizure: comparisons to sibling controls and effects of prior unrecognized seizures. Annual meeting of the American Epilepsy Society, Seattle, December 9, 2002.
89. Koop JI, Fastenau PS, McCall TJ, Dunn DW, Austin JK. Degree of sleep attained during EEG as a moderator of the relationship between spike-wave discharges and neuropsychological performance. Annual meeting of the American Epilepsy Society, Seattle, December 9, 2002.
90. Austin JK, Dunn DW, Caffrey HM, Perkins SM, McNelis AM. Recurrent seizures and teachers’ ratings of behavior problems. Annual meeting of the American Epilepsy Society, Seattle, December 9, 2002.
91. Buelow JM, Austin JK, Perkins SM, Shen J, Dunn DW, Fastenau PS. The interaction of gender and IQ in behavior and self-concept in children with epilepsy. Annual meeting of the American Epilepsy Society, Seattle, December 9, 2002.
92. McNelis AM, Austin JK, Huberty TJ, Dunn DW. Factors associated with academic achievement in children with recent-onset seizures. Annual meeting of the American Epilepsy Society, Seattle, December 10, 2002.
93. Koop JI, Fastenau PS, McCall TJ, Austin JK, Dunn DW. Sleep as a moderator of the relationship between spike-wave discharges and behavior. Annual Meeting of the International Neuropsychological Society, Honolulu, February 2003.
94. Dunn DW, Austin JK. Psychosocial and environmental influences in epilepsy in children. Symposium on Chronic Diseases in Childhood and Adolescence: from etiology to Prevention. Kiel, Germany, June 19, 2003.
95. Dunn DW. Differential diagnosis of psychiatric disorders in children and adolescents: association of depression, psychosis, anxiety, aggression, and ADHD. Miami, Child Neurology Society, 32nd Annual Meeting, October 2, 2003.
96. Lewis D, Linder S, Kurlan R, Winner P, Dunn D, Sallee F, Dure L, Erenberg G, Mintz M, Milton D, Schuh K, Allen AJ, Kelsey D. Atomoxetine for the treatment of attention deficit hyperactivity disorder and comorbid tics in children. Child Neurology Society 32nd Annual Meeting. Miami, October 2, 2003.
97. Dunn DW, Austin JK, Perkins SM. Sleep disruption and behavioral problems in children with new-onset seizures. Child Neurology Society 32nd Annual Meeting. Miami, October 2, 2003.
98. Dunn D, Allen A, Thomason C, Zhang S, Michelson D, Kelsey D. Efficacy of atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder. Child Neurology Society 32nd Annual Meeting. Miami, October 3, 2003.
99. Dunn DW. Treating mental health problems at home and at school. 25th International Epilepsy Congress. Lisbon, Portugal October 16, 2003
100. Austin JK, Dunn DW, MacLeod JS, Shen J, Perkins, SM. Instruments to measure stigma in children with epilepsy and their parents: initial development and testing. Annual Meeting of the American Epilepsy Society. Boston, December 8, 2003.
101. Fastenau PS, Johnson CS, Byars AW, Austin JK, Dunn DW, Perkins SM. Neuropsychological functioning at first recognized seizure: comparisons between seizure types. Annual Meeting of the American Epilepsy Society. Boston, December 9, 2003.
102. Buelow JM, Dunn DW, Austin JK, Perkins SM, Shinnar S. Development of the epilepsy syndrome severity scale-child (ESSS-C). Annual Meeting of the American Epilepsy Society. Boston, December 9, 2003.
103. Dunn DW, Austin JK, Johnson CS, Perkins SM, McNelis AM. Academic achievement in children with new-onset seizures. Annual Meeting of the American Epilepsy Society. Boston, December 9, 2003.
104. Marynchenko M, Secnik K, Allen AJ, Birnbaum HG, Dunn D. Epilepsy patients with attention-deficit/hyperactivity disorder: prevalence and cost of care. 9th Annual Meeting of the International Society for Pharmacoeconomics and Outcome Research. Arlington VA, May 16-18, 2004.
105. Kronenberger WG, Mathews VP, Dunn DW, Wang Y, Wood EA, Giauque AL, Rembusch ME, Larsen JJ, Kalnin AJ, Li TQ. Adolescent aggressive behavior and parent awareness of media violence exposure. American Psychological Association. Honolulu, July 2004.
106. Dunn DW, Kronenberger WG. Efficacy of atomoxetine in the treatment of children and adolescents with ADHD. XIV Annual Symposium of the Child Neurology Section of the International School of Neurological Sciences. San Servolo, Venice, Italy, September, 2004.
107. Dunn D, Lipkin P. ADHD: rating the rating scales. 33rd Annual Meeting of the Child Neurology Society. Ottawa, Ontario, Canada, October 14, 2004.
108. Dunn DW, Austin J, Perkins S, Johnson C. Behavior problems in children with new-onset seizures. 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Washington DC, October 20, 2004.
109. Warren MJ, Dunn DW, Rushton JL. Outcome measures of triple board graduates: 1991-2003. 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Washington DC, October 21, 2004.
110. Dunn DW, Austin JK, Johnson CS, Perkins SM. Do attention problems and internalizing problems predict seizure recurrence in children? American Epilepsy Society, New Orleans, LA, December 7, 2004.
111. Dunn DW. ADHD, attentional problems, and childhood temporal lobe epilepsy. Progress in Epileptic Disorders Workshop: Cognitive Dysfunction in Children with Temporal Lobe Epilepsy. Rome, Italy, 4 March 2005.
112. Dunn DW. Factors affecting cognitive performance in children with epilepsy. Disease Modification in Epilepsy. New York City, 30 April 2005.
113. Dunn DW. Are SSRI safe and effective for children and adolescents? Mental Health Symposium. Indianapolis, 13 May 2005.
114. Dunn DW, Turgay A, Weiss M, Dickson R, Feldman PD, Sher L, Melmed RD, Saylor K, Busner J, Ramsey JL, Allen AJ. Use of plasma concentration to guide atomoxetine doses in ADHD patients. American Psychiatric Association, 158th Annual Meeting. Atlanta, 24 May 2005.
115. Dunn DW. Mood disorders in children with epilepsy. American Psychiatric Association, 158th Annual Meeting. Atlanta, 26 May 2005.
116 Dunn DW, Kronenberger WG. Treatment of attention disorders in children with epilepsy. 26th International Epilepsy Congress, Paris, 29 Aug 2005.
117. Dunn DW. Behavioral and cognitive problems in children with epilepsy. Grand rounds, University of Iowa Carver College of Medicine, Department of Psychiatry, 10 Oct 2005.
118. Dunn DW. PTSD: local and global. Department of Pediatrics, University of Iowa Carver College of Medicine, 11 Oct 2005.
119. Dunn DW. Seizures in an ADHD population. ADHD Global Medical Conference. Toronto Canada, 17 Oct 2005.
120. Dunn DW. Mental Health Issues in Adults with TSC. Southern Regional TSC Conference. Dallas TX, 5 November 2005.
121. Dunn DW, Fastenau PS, Austin JK, Perkins SM. Neuropsycholoigcal functioning over time in children with epilepsy. American Epilepsy Society. Washington DC, 4 Dec 2005.
122. Dunn DW. Behavioral and cognitive comorbidities in children with epilepsy. 2005 Presidential Symposium. American Epilepsy Society. Washington DC, 5 Dec 2005
123. Dunn DW. Depression in children. 4th Annual Pediatric Neurology Update, Louisville KY, 3 Feb 2006.
124. Dunn DW, Kronenberger WG, Giauque AL, Lafata DE, Maxey LE. Improvement in specific aggressive outbursts in adolescents with ADHD following augmentation of methylphenidate with quetiapine. American Psychiatry Association 159th Annual Meeting, Toronto, 24 May 2006.
125. Dunn DW. Attention, ADHD, and epilepsy. Kindling theory, crossing the bridge between epilepsy and psychiatry. Domaine des Vaulx de Cernay, 11 Jun 2006.
126. Dunn D. Problems with attention in children with epilepsy. 10th International Child Neurology Congress, Montreal, 15 Jun 2006.
127. Dunn DW. 1. Aggressive Behavior Management 2. Mood and behavioral disorders in children with TSC. 2006 National TSC Conference. Chicago, 15 Jul 2006.
128. de Vries P, Dunn DW. Sexual issues of development. 2006 National TSC Conference. Chicago 16 Jul 2006.
129. Dunn DW. Treatment of attention disorders in children with epilepsy. Neuropediatrics and ADHD. Cancun 26 Aug 2006.
130. Kronenberger W, Dunn D. Attention deficit/hyperactivity disorder and dyslexia. International Dyslexia Association Annual Conference. Indianapolis IN 10 Nov 2006.
131. Dunn DW, Austin JK, Johnson CS, Perkins SM. Does behavior in children improve with the treatment of seizures? Ab. 1.228. 2006 Annual Meeting of the American Epilepsy Society, San Diego CA, 3 Dec 2006.
132. Dunn DW. Behavioral and cognitive problems in children with epilepsy. UMDNJ-RWJMS Department of Psychiatry Grand Rounds Lecture Series. New Brunswick, NJ, 3 May 2007.
133. Dunn DW. Treatment of mood disorders in children with epilepsy. 27th International Epilepsy Congress, Singapore, 9 July 2007.
134. Dunn DW. Psychiatric comorbidities in children and adults with epilepsy. Professionals in Epilepsy Care. American Epilepsy Society annual meeting. Philadelphia, 1 Dec 2007.
135. Dunn DW, deGrauw TJ, Johnson CS, Perkins SP, Austin JK. Risk factors at baseline for persistent seizures after a first recognized seizure. American Epilepsy Society annual meeting, Philadelphia, 1 Dec 2007.
136. Kronenberger WG, Dunn DW. Development of a very brief, user-friendly measure of ADHD for busy clinical practices: The CHAOS scale. Poster presented at the 2008 National Conference on Child Health Psychology, Miami, FL, 11 Apr 2008.
137. Dunn DW. When the mind meets the brain. The 2008 M. V. Arunachalam Oration. Chennai, India, 16 Aug 2008.
138. Dunn DW. 1. The neuropsychiatric evaluation of a child. 2. Cerebral palsy and intellectual impairment. 3. The neurological approach to childhood behavioural dysfunction. 4. Marker of behavioural dysfunction in the child and young adult. Essential Neurology for the Psychiatrist. Chennai, India, 16-17 Aug 2008.
139. Dunn DW, Austin JK, Johnson CS, Perkins SM. Family functioning and psychopathology in children and adolescents with epilepsy. American Academy of Child and Adolescent Psychiatry, Chicago, 1 Nov 2008.
140. Dunn D, deGrauw T, Johnson C, Perkins S, Austin J. Relationship between seizure risk factors and mental health outcomes in children. American Epilepsy Society annual meeting, Seattle, 7 Dec 2008.
141. Dunn DW. Behavioral and emotional problems of children: prevalence and diagnosis. Indiana Psychiatric Society spring symposium, Indianapolis, 25 Apr 2009.
142. Dunn DW. New developments in child psychiatry, Mental Health symposium, Indianapolis, 5 Jun 2009
143. Dunn DW. Attention Deficit Hyperactivity Disorder. Fifth International Conference on Isodicentric 15 and Related Disorders, Indianapolis, 25 Jun 2009.
144. Block SL, Williams D, Ruberg S, Donnelly C, Dunn D, Saylor K. Early changes in selected attention-deficit/hyperactivity disorder rating scale items for predicting longer-term response to atomoxetine in pediatric patients. American Academy of Child and Adolescent Psychiatry 56th Annual Meeting, Honolulu, HI, Oct 2009.
145. Dunn DW, Johnson CS, Byars AW, deGrauw TJ, Fastenau PS, Perkins SM, Austin JK. Academic problems in children with seizures: relationships over time with neuropsychological functioning and family variables. American Epilepsy Society annual meeting, Boston, 6 Dec 2009.
146. Dunn DW. Suicide in children and adolescents. Psychiatry Special Interest Group, American Epilepsy Society annual meeting, Boston, 8 Dec 2009.
147. Baram TZ, Caplan R, Dunn D, Sankar R. Depressive disorders in children and adolescents, a roundtable presentation. Epilepsy and Depressive Disorders Conference. Chicago IL, 13 Sep 2010
148. Caplan R, Dunn D, Jones J, Sankar R. Treatment of mood disorders in pediatric populations form the perspective of the neurologist, neuropsychologist, and psychiatrist. Epilepsy and Depressive Disorders Conference. Chicago IL, 13 Sep 2010
149. Dunn DW, Kronenberger WG. Autistic spectrum disorder and attention deficit hyperactivity disorder in childhood epilepsy. Neuropsychology and Its Role in the Care of People with Epilepsy. Progress in Epileptic Disorders Workshop, Toronto, Canada, 5 Nov 2010.
150. Dunn DW, Johnson CS, Fastenau PS, Byars AW, deGrauw TJ, Perkins SM, Austin JK. Are antiepileptic drugs associated with suicidal ideation in children with new-onset seizures? American Epilepsy Society annual meeting. San Antonio TX, 6 Dec 2010 (invited presentation at Pediatric Epilepsy Highlights Session and poster 3.261).
151.Wietecha L, Williams D, Shaywitz S, Shaywitz B, Hooper S, Wigal SB, Dunn DW, McBurnett K. Efficacy of treatment with atomoxetine for attention in children and adolescents with ADHD and comorbid dyslexia. American Academy of Child and Adolescent Psychiatry annual meeting, Toronto, 19 Oct 2011 (Abstract 1.2)
152. Dunn DW. Epilepsy and Psychopathology: Differential Diagnosis. Clinical Perspectives 11, Pediatric topics in child psychiatry: epilepsy, neurodevelopmental disorders, and gynecological health. American Academy of Child and Adolescent Psychiatry annual meeting, Toronto, 20 Oct 2011.
153. Fastenau PS, Johnson CS, Byars AW, deGrauw TJ, Dunn DW, Austin JK. Prospective neuropsychological data from healthy siblings before and after the very first seizures. Ab 2.001. American Epilepsy Society annual meeting, Baltimore, Pediatric Highlights, 5 Dec 2011; abstract published in Epilepsy Currents 2012;12 (Suppl 1): 414.
154. Dunn DW. Neuropsychological functioning in children with seizures. Neurodevelopmental Disorders Course. American Academy of Neurology annual meeting, New Orleans, 27 April 2012.
155. Szczepaniak D, Dunn DW. Psychopharmacology in children. 47th Annual Riley Hospital for Children at IU Health Conference. Indianapolis, 10 May 2012.
156. Dunn DW. Depression and anxiety in children with epilepsy: are they epilepsy dependent? Outcome of Childhood Epilepsies. Progress in Epileptic Disorders Workshop 2012. The Hague, the Netherlands, 18 November 2012.
157. Dunn DW. Interictal dysphoric disorder and children with epilepsy. Psychiatry interest group. American Epilepsy Society annual meeting. San Diego CA, 30 Nov 2012.
158. Dunn DW, Rentz A, Skalicky A, Pelletier C, Liu Z, Prestifilippo J, Nakagawa J, Frost M, Wheless J, Pashos C. Characteristics and burden of subependymal giant cell astrocytomas (SEGAs) in patients with tuberous sclerosis complex: results of a patient and caregiver survey. (P07.016). 2013, American Academy of Neurology 65th Annual meeting. San Diego CA 21 Mar 2013.
159. Dunn DW. Autistic spectrum disorder and course moderator for Psychopharmacology for autism, depression, and anxiety. 48th Annual Pediatric Conference. Indianapolis IN, 30 May 2013.
160. Quality of life and Tuberous Sclerosis:
a. Skalicky AM, Rentz AM, Liu Z, et al. Tuberous sclerosis complex in the US: patient-reported physical and mental health burden.
b. Wheless JW, Rentz AM, Skalickly AM, et al. Health care resource utilization in tuberous sclerosis complex in the United States.
c. Rentz AM, Skalicky AM, Liu Z, et al. The economic burden of tuberous sclerosis complex on families in the United States.
d. Dunn DW, Rentz AM, Skalicky AM, et al. Humanistic burden of tuberous sclerosis complex on patient caregivers in the United States.
2013 International Research Conference on Tuberous Sclerosis Complex and Related Disorders. Washington, DC, 20-23 June 2013.
161. Dunn DW. Epilepsy comorbidities and their impact on learning. 30th International Epilepsy Congress. Montreal, Quebec, Canada, 23 Jun 2013.
162. Dunn DW.
a. What about genetic screening for childhood epilepsies.
b. Status of newer AEDs in management of childhood epilepsies.
c. Cognitive and behavioral issues in children with epilepsy: autistic disorder and ADHD.
d. Cognitive and behavioral issues in children with epilepsy: anxiety and depression.
e. Psychosocial issues in children with epilepsies.
International Workshop on Epilepsy. New Delhi, India, 14-16 Feb 2014.
163. Dunn DW. Promoting Mental Health in Low Income Countries. St. Vincent Family Medicine Global Health Conference. Indianapolis, 6 Mar 2014.
164. Besag F, Aldenkamp A, Caplan R, Dunn D, Gobbi G, Sillanpaa M. Psychiatric and behavioural disorders in children with epilepsy: report of the child neuropsychiatry taskforce, neuropsychobiology commission, Internal League against Epilepsy. European Congress on Epileptology annual meeting, Stockholm, Jun/Jul 2014.
165. Dunn DW. (moderator)
a. Seizure management and impact on mood, behavior and sleep in adults with TSC.
b. Autism spectrum disorder and therapeutic options
2014 World TSC Conference. Washington DC, 4-5 July 2014.
166. Dunn DW. Psychopharmacology of ADHD. 38th Annual Arthur B. Richter Conference. Carmel IN. 27 Feb 2015.
167. Dunn D and Paddock L. ADHD in the home and school. 50th Annual Riley Hospital for Children at IU Health Pediatric Conference. Indianapolis, 16 May 2015.
168. Dunn D. ADHD: Diagnosis, Assessment, and Treatment. 18th Annual Mental Health Symposium. Indianapolis 29 May 2015
169. Dunn DW. Psychotic symptoms and neurologic testing. American Academy of Child and Adolescent Psychiatry 62nd Annual Meeting, San Antonio TX. 27 Oct 2015
170. Dunn DW. The role of the neurologist in the management of psychogenic non-epileptic seizures. American Academy of Child and Adolescent Psychiatry 62nd Annual Meeting, San Antonio TX. 28 Oct 2015
171. Dunn DW. Pediatric psychopharmacology: What Works and what are the problems. 2015 Pediatric Conference. Evansville IN 11 Nov 2015.
172. Dunn DW. Medications for anxiety and depression. 51st Annual Riley Hospital for Children Pediatric Conference. Indianapolis IN, 11 May 2016.
173. Dunn DW. ADHD: Comorbidity and its Effect on Treatment. 2016 Annual Meeting of the Association of Medicine and Psychiatry. Chicago, 2 Oct 2016.
174. Dunn DW, Blake HS. Headaches in Children and Adolescents: Co-morbidity with Behavioral and Emotional Problems. Clinical Perspectives 12. 63rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry. New York City, 25 October 2016.
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- curriculum vitae template word document
- curriculum vitae finance manager sample
- curriculum vitae format in word
- curriculum vitae sample doc
- curriculum vitae sample pdf
- curriculum vitae samples for teachers
- curriculum vitae template free download
- curriculum vitae template word download
- nursing curriculum vitae template pdf
- best curriculum vitae format
- curriculum vitae en francais modele
- curriculum vitae examples word